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ABSTRACT
Stroke can be caused by focal ischemia due to cerebral artery occlusion or by global
ischemia that occurs when global blood supply to the brain is interrupted. The acute
phase of ischemic brain injury is followed by a more prolonged period of
revascularization and repair that can last for several months. One hallmark of this repair
phase includes an endogenous neural stem/progenitor cell (NSPC) regenerative response
that occurs concomitant with angiogenesis. Several studies suggest that the cytogenic
response is beneficial for recovery following stroke, however, more studies need to be
done to determine whether the beneficial effects are due to functional replacement of lost
neurons and/or due to nutritive functions of the NSPCs for penumbral tissue.
Therapeutic targeting of regeneration and repair phases of stroke will require an
understanding of NSPC function, particularly under conditions of hypoxia/ischemia.

vi

This dissertation is focused on elucidating the metabolic properties of NSPCs that allow
them to withstand sudden onset and prolonged hypoxia, and the mechanisms by which
NSPCs may provide neuroprotection against ischemic damage. We found that NSPCs
express stabilized hypoxia-inducible factor-1 (HIF-1) under normoxic conditions, a
transcription factor that has been shown to regulate a variety of genes including those
involved in angiogenesis, neuroprotection, and glycolytic metabolism.

In this

dissertation, we show that, in vitro, HIF-1 expression in NSPCs mediates the ability of
NSPCs to provide protection to neurons that undergo oxygen-glucose deprivation through
regulation of vascular endothelial growth factor. We also show that HIF-1 is required
for NSPCs to survive 24 h anoxia in culture. We determined that NSPCs appear to
produce most of their ATP via glycolysis, although the metabolic phenotype of NSPCs
under normoxic conditions does not appear to be regulated by HIF-1. To determine
whether NSPCs display similar properties in vivo, we created a nestin-CreERT2/R26RYFP/Hif1afl/fl mouse that could simultaneously express yellow fluorescent protein and
delete Hif1a specifically in nestin-positive NSPCs following tamoxifen administration.
The results of these experiments increase our understanding of endogenous NSPC
properties under hypoxic conditions and form the basis for future studies that aim to
therapeutically manipulate NSPC function for facilitating brain repair.
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1. Introduction
1.1 Clinical impact of ischemic stroke
Stroke is the third cause of death and first cause of debilitation in first-world countries
(Feigin et al., 2003).

Approximately 80% of strokes are ischemic, rather than

hemorrhagic, and cause a significant social burden(Feigin et al., 2003). Ischemic stroke
results from a transient or permanent reduction of cerebral blood flow, usually caused by
the occlusion of a major cerebral artery by local thrombosis (blood clot) or an embolus
(free-moving blood clot) (Dirnagl et al., 1999). Blood carries the two main substrates
required for energy production in the brain, oxygen and glucose. Glucose is metabolized
for the production of the main cellular energy source, adenosine triphosphate (ATP), via
glycolysis, alone or in combination with mitochondrial metabolism. Oxygen is required
to produce ATP within the mitochondria, but not for ATP production via glycolysis.
Following artery occlusion, lack of blood flow to the surrounding tissue results in
immediate acute injury followed by more prolonged inflammatory and repair processes
that persist for months. At the core of the ischemic infarct, ATP depletion results in
edema and death of endothelial and neuronal cells by necrosis (Krupinski et al., 1994;
Dirnagl et al., 1999). In the penumbral region surrounding the infarct, neurons undergo
programmed cell death (apoptosis). A few hours following stroke, the blood-brain barrier
begins to break-down, microglial cells are activated, and astrocytes become reactive
(Dirnagl et al., 1999). Within one to two days, the brain becomes infiltrated by bloodborne inflammatory cells including neutrophils, monocytes, and lymphocytes (Dirnagl et
al., 1999; Moskowitz et al., 2010). Initial efforts by the brain to repair the vasculature
and infarcted cortical tissue are seen approximately one week following the initial stroke
1

and can last for many months (Thored et al., 2007). Thus, ischemic stroke stimulates an
evolving continuum of events that transition from acute injury to chronic phases of brain
repair.
Therapeutic targets of ischemic stroke have been aimed at altering the endogenous injury
and repair processes. However, numerous clinical trials targeting mechanisms of injury
have failed to improve post-stroke outcome (Moskowitz et al., 2010). Currently, the only
FDA-approved therapy to treat ischemic stroke is the use of a thrombolytic agent
involved in the breakdown of blood clots, known as recombinant tissue plasminogen
activator (tPA). However, less that 10% of patients receive tPA treatment due to a small
therapeutic window (3 hours) and increased risk of hemorrhage if administered once the
blood-brain barrier opens (Moskowitz et al., 2010). With limited treatment options, it is
critical that researchers develop ways to extend the therapeutic window for ischemic
stroke and improve post-stroke rehabilitation. Whether the endogenous repair processes
can be therapeutically targeted remains to be determined.
To study post-stroke events in the laboratory, various models can be employed including
the use of animals as well as cell culture. Ischemic stroke is modeled by occluding blood
flow to the animal brain transiently, followed by reperfusion (reintroduction of blood
flow). Focal cerebral ischemia can be induced in the mouse by occluding the middle
cerebral artery (MCA) using a nylon filament. In culture, the effects of ischemia are
modeled by transiently depriving cells of oxygen and glucose, the substrates carried by
blood that are necessary for ATP production. Transient oxygen and glucose deprivation
(OGD) is a well-characterized in vitro model that has been used to mimic ischemiainduced programmed cell death in neurons (Goldberg and Choi, 1993; Martin-Villalba et
2

al., 2001; Plesnila et al., 2001; Wetzel et al., 2008). The in vitro OGD cell culture model
is useful to investigate isolated cellular responses to ischemic injury. In this dissertation,
we employ both in vivo and in vitro models of ischemic stroke to study endogenous
repair mechanisms, to specifically understand how murine neural stem/progenitor cells
survive severe hypoxia as well as protect neurons. The overarching hypothesis of this
dissertation is that hypoxia-inducible factor-1 alpha (HIF-1) plays an essential role in
the regulation of neural stem/progenitor cell function in vitro and in vivo under both
normal and hypoxic conditions.

1.2 Adult Neural Stem/Progenitor Cells
1.2.1 Stem cell definition
The term “stem cell” refers to phenotypically uncommitted cells with the ability to selfrenew and give rise to specialized cells that make up the tissues and organs of the body.
These uncommitted cells can undergo asymmetric cell division to give rise to a new stem
cell and a cell of more restricted lineage fate. Stem cells can be isolated from embryos
(embryonic stem cells; ESCs), adult organs (adult stem cells), and can be artificially
induced from fully differentiated cell types through genetic manipulation (induced
pluripotent stem cells; iPSCs). Stem cells represent key research tools for understanding
embryonic development and mechanisms of disease. In addition, stem cells have a wide
array of potential therapeutic applications for functional replacement of differentiated
cells that are lost to injury or disease (e.g., diabetes, cardiovascular disease,
neurodegeneration). Thus, unraveling the mysteries of stem cell biology is important for
advancing basic medical science and for therapeutic applications in regenerative
medicine.
3

1.2.2 Neural stem/progenitor cells in the adult brain
The adult mammalian brain harbors two germinal centers in which neural
stem/progenitor cells reside and give rise to new neurons and glia throughout adulthood.
These include the subgranular zone (SGZ) of the dentate gyrus of the hippocampus,
which gives rise to new dentate granule neurons, and the subventricular zone (SVZ)
surrounding the lateral ventricles, which gives rise to new neurons within the adult
olfactory bulb (Eriksson et al., 1998; Gage, 2000; Doetsch, 2003a; Alvarez-Buylla and
Lim, 2004). The production of new neurons throughout adulthood is conserved across
many species including human (Eriksson et al., 1998; Macas et al., 2006; Curtis et al.,
2007). Neural stem/progenitor cells that reside in the germinal centers of the adult brain
are self-renewing, multipotent cells that give rise to neuronal, astrocyte and
oligodendrocyte lineages (Martino and Pluchino, 2006).
The terminology defining mitotically active multipotent cells in the adult brain has been
argued.

Many investigators refer to these cells collectively as neural stem cells,

recognizing that they are restricted to a CNS phenotype yet acknowledging their selfrenewal and multipotentiality. Other investigators prefer the term neural stem/progenitor
cell to indicate their restriction to neural cell fates. Throughout this dissertation, we
utilize the term neural stem/progenitor cells (NSPCs) to define this population.

1.2.3 SVZ and Adult Olfactory Neurogenesis
Within the SVZ, radial glial-derived astrocytic stem cells are termed type B cells. These
cells are slowly proliferating cells, but give rise to rapidly dividing transient amplifying
progenitor cells (type C cells). Transient amplifying progenitors within the SVZ have the
potential to give rise to both neurons and glial cell types. In vivo, under non-pathological
4

conditions, most stem cells give rise to doublecortin (Dcx)-positive migrating neuroblasts
which form a rostral migratory stream to the olfactory bulb to become mature
interneurons that integrate into the olfactory bulb circuitry (Riquelme et al., 2008) (Figure
1.1).

Figure 1.1: Cytoarchitecture of the subventricular zone (SVZ). The adult mouse
SVZ is located adjacent to the lateral ventricle (LV). Type B cells (SVZ astrocytes)
divide slowly and have the ability to divide symmetrically to give rise to another stem
cell, or divide asymmetrically to give rise to Type C transient amplifying progenitor cells.
Type A doublecortin-positive neuroblasts differentiate from Type C cells. The wall of
the lateral ventricle is lined with ependymal cells (E) that directly contact SVZ
progenitors. Blood vessels (BV) and basal lamina (BL) also directly contact the cells of
the SVZ. Figure adapted from(Riquelme et al., 2008).

1.2.4 SGZ and Hippocampal Neurogenesis
In addition to the SVZ, radial glial-like neural stem cells also persist within the adult
SGZ. The cytoarchitecture of the SGZ differs from that of the SVZ. Within the SGZ,
radial glial-derived stem cells give rise to transient amplifying progenitor cells that
migrate only a short distance into the granule cell layer of the dentate gyrus, where they
5

give rise to newborn dentate granule neurons (Figure 1.2).

Adult hippocampal

neurogenesis is thought to be important for learning and memory processes, since
ablation of adult hippocampal neurogenesis attenuates spatial learning, whereas
stimulation of hippocampal neurogenesis improves learning ability (Zhao et al., 2008).
Radial glial-like stem cells within the SVZ and SGZ express the glial marker, glial
fibrillary acidic protein (GFAP) as well as the stem cell markers nestin and prominin.

Figure 1.2: Cytoarchitecture of the subgranular zone (SGZ). In the adult mouse
brain, type B SGZ astrocytes proliferate and give rise to intermediate precursors which
progressively generate more differentiated progeny (D1, D2, D3) including immature
neurons. Immature neurons migrate a short distance into the granule cell layer of the
dentate gyrus, where mature granule neurons (G) integrate into the circuitry of the dentate
gyrus through extension of dendrites into the molecular layer and an axon along the
mossy fiber pathway. Blood vessels (BV) and basal lamina (BL) directly contact the
cells of the SGZ. Figure adapted from (Riquelme et al., 2008).

6

1.2.5 NSPC lineage fate
In the adult brain, neural stem/progenitor cells give rise primarily to neurons
(neurogenesis) under non-pathological conditions, but can also give rise to a small
number of astrocytes and oligodendrocytes (gliogenesis). Injury, expansion in culture, or
transplantation of NSPCs into non-neurogenic regions (outside the SVZ or SGZ) results
in a predominant gliogenic differentiation fate (Herrera et al., 1999; Li et al., 2010).
Lineage fate is most-likely determined by extrinsic factors within the local environment,
such as growth factors and cytokines (Kokovay et al., 2008).

Interestingly,

transplantation of stem cells from spinal cord, a non-neurogenic region, into the
hippocampus generates neurons (Shihabuddin et al., 2000). That some regions of the
brain promote neuronal vs. glial differentiation suggests that the stem cell
microenvironment determines lineage fate. Differences in lineage fate of the injured
brain may contribute to repair processes.

1.3 Neural stem/progenitor cell (NSPC) response to stroke
NSPCs within the SVZ and SGZ mount regenerative responses following many types of
metabolic and traumatic brain injuries, making them an attractive therapeutic target for
promoting structural and functional brain repair. Stroke-induced neurogenesis was first
described following transient global cerebral ischemia in gerbils, which stimulated
increased neurogenesis in the dentate gyrus (Liu et al., 1998). Later studies demonstrated
that focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO) in rats
stimulated ectopic migration of hundreds of thousands of neuroblasts from the SVZ into
the ischemic striatum (Arvidsson et al., 2002). MCAO has been shown to reduce the

7

partial pressure of oxygen in the SVZ to below 1.4%, yet cells in this region survive this
hypoxic event and mount a proliferative and migratory response (Thored et al., 2007).
The SVZ cytogenic response to focal ischemia is delayed and of long duration, such that
peak proliferation in the SVZ occurs 7 days following MCAO, and migration out to the
lesion continues for up to one year in rodents (Zhang et al., 2004; Thored et al., 2007).
Our laboratory has recently demonstrated that the SVZ response to stroke encompasses
multilineage cytogenesis whereby SVZ NSPCs generate new oligodendrocyte
progenitors, astrocytes, and neuroblasts (Li et al., 2010) (and Appendix).
The endogenous SVZ cytogenic response may be important for structural and functional
recovery following stroke. In rodents, spontaneous improvements in behavioral deficits
and cognitive function following focal ischemia are temporally correlated with the onset
of neurogenesis (Kondziolka et al., 2000; Zhang et al., 2003b). Maysami and colleagues
demonstrated that depletion of NSPCs by mitotic inhibition (using methylazoxymethanol;
MAM), or by inducible depletion of GFAP+ NSPCs (using ganciclovir in GFAP/HSVTK mice), significantly attenuated ischemic tolerance, suggesting a role for endogenous
progenitors in the protective effect of ischemic tolerance (Maysami et al., 2008). More
recently, Jin and colleagues demonstrated that depletion of migrating neuroblasts in
ganciclovir-treated Dcx/HSV-TK mice results in exacerbated motor deficits and
expansion of infarct size (Jin et al., 2010a).
Much evidence suggests a functional link between the SVZ regenerative response and
angiogenesis that occurs during the repair phase of stroke injury. Following MCAO and
bilateral common carotid artery occlusion, reactive astrocytes and blood vessels appear to
provide the physical substrate for neuroblast migration (Ohab et al., 2006; Yamashita et
8

al., 2006). Endothelial cells have been shown to produce factors that promote neural
stem/progenitor cell proliferation, neuroblast migration, and neuronal differentiation
(Shen et al., 2004). These include brain derived neurotrophic factor (BDNF) (Leventhal
et al., 1999), stromal-derived factor 1 (SDF-1) (Kokovay et al., 2010), and angiopoietin 1
(Ang1) (Ohab et al., 2006), and other as yet undefined factors. Thus, angiogenesis and
neurogenesis appear to be inextricably linked, and this has led to the concept of a
“neurovascular niche” important for maintaining neural stem cell function under both
normal physiological and pathological conditions.
While rodent models of stroke allow researchers to study the mechanisms involved in
pathological processes, it is important to understand if these models translate to human
disease.

To study the cytogenic response in post-mortem tissue, antibodies can be

utilized that are directed against proteins known to be expressed in neural stem/progenitor
cells and their progeny. To study proliferation, the marker Ki67 can be used to detect all
active phases of the cell cycle. Because NSPCs proliferate in response to injury, and
most other cells in the brain are post-mitotic, Ki67 is a popular marker to study the NSPC
response to stroke. Antibodies can also be used to determine lineage fate (Figure 1.3),
including a marker for immature neuronal committed progenitors known as
polysialylated neural cell adhesion molecule (PSA-NCAM), as well as the immature
neuronal marker neuron-specific class III beta-tubulin (Tuj1).

9

Figure 1.3: Markers used to identify cell types in the SVZ. SVZ astrocytic stem cells
(Type B cells) express the markers GFAP and nestin. Nestin expression is retained in
transient amplifying progenitor cells (Type C cells), which also express Dlx2. Migrating
Type A neuroblasts express PSA-NCAM and Dcx, markers which are retained into
immature neurons. Immature neurons express Tuj1 and mature neurons express NeuN.
Each of these markers can detected using antibodies against these proteins. Adapted
from (Ming and Song, 2005) and(Abrous et al., 2005).

To investigate whether humans exhibit an NSPC response to stroke, Jin and colleagues
compared Ki67 staining of post-mortem tissue from the cerebral cortices of stroke
patients versus patients who died without brain pathology. They reported increased
Ki67-immunoreactive cells in the tissue of stroke patients (Jin et al., 2006). Later that
year, Macas and colleagues reported that following stroke, patients exhibited increased
Ki67-immunoreactive cells in the ipsilateral SVZ, as well as increased PSA-NCAM, near
the walls of the lateral ventricle (Macas et al., 2006). Recently, Marti-Fabregas and
colleagues confirmed increased Ki67-immunoreactive cells, and also discovered an

10

increase in the number of Tuj1- or PSA-NCAM-positive cells, in the ipsilateral SVZ
following stroke (Marti-Fabregas et al.). Therefore, there is evidence of a neurogenic
response to stroke in humans. Understanding the role of the endogenous NSPC response
to stroke is important for understanding brain repair mechanisms. Ultimately, NSPC
survival and directed lineage fate may be important therapeutic goals to improve recovery
from brain injury in humans (Zhang et al., 2005; Lichtenwalner and Parent, 2006;
Taupin, 2006).

1.4 Hypoxia-inducible factor-1 (HIF-1)
Our interest in the mechanisms that support NSPC survival and replenishment of
damaged cells within the ischemic brain led us to explore the role of hypoxia-inducible
factor-1 (HIF-1). HIF-1 is a well-known mediator of adaptive cellular responses to
hypoxia through direct transcriptional regulation of cellular metabolism (Semenza,
2010b). Evidence also points to a novel role of HIF-1 in maintainance of the neural
stem/progenitor cell phenotype (Gustafsson et al., 2005).
HIF-1 is most widely recognized for its role in the adaptive response to hypoxia through
transcriptional regulation of metabolism. In most cell types, the level of HIF-1 is posttranslationally regulated in an oxygen-dependent manner. Under normoxic conditions,
prolyl hydroxylase domains (PHD) use molecular oxygen (O2), 2-oxoglutarate, and iron
(II) to drive hydroxylation of proline residues on HIF-1 protein, as well as the
production of carbon dioxide (CO2) and succinate(Freeman et al., 2003). HIF-1 protein
is constitutively produced, but has a cellular half-life of less than 5 minutes due to
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Figure 1.4: Stabilization and transcriptional targets of HIF-1. HIF-1 is targeted
for proteasomal degradation under normoxic conditions. Under hypoxia, HIF-1 is
stabilized due to decreased prolyl hydroxylase domain (PHD) activity and can enter the
nucleus to interact with HIF-1/ARNT and drive transcription of target genes. Examples
of HIF-1 regulated genes include vascular endothelial growth factor (VEGF),
erythropoietin (EPO), glycolytic enzymes, and glucose transporters. Figure adapted from
the following publications: (Sharp et al., 2000; Semenza, 2003; Yeo et al., 2004).

rapid proteosomal degradation promoted by prolyl hydroxylation and association with the
von Hippel Lindau protein (VHL) (Semenza, 2003; Weidemann and Johnson, 2008).
Under conditions of hypoxia, prolyl hydroxylase activity decreases and unhydroxylated
HIF-1 rapidly accumulates within the nucleus.

There, HIF-1 dimerizes with the

oxygen-independent HIF-1 subunit (ARNT [aryl hydrocarbon receptor nuclear
translocator]), forming the HIF-1 transcriptional complex that regulates target genes
through cis-acting hypoxia response elements (HREs) (Semenza, 2003). Well-known
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HIF-1 target genes include those that promote glycolysis and angiogenesis (Figure 1.4)
(Yeo et al., 2004).

1.4.1 HIF-1-regulated genes
In cancer cells, HIF-1 has been shown to regulate the transcription of hundreds of target
genes, including those involved in angiogenesis, growth factor signaling, glucose and
energy metabolism, metastasis, and stem cell maintenance (Semenza, 2010a). HIF-1
has been well-characterized in cancer models due to its expression under hypoxia and its
influence on tumor vascularization.
1.4.1.1 HIF-1 regulation of angiogenesis and neurogenesis
HIF-1 was first described for its ability to mediate transcription of hypoxia-inducible
erythropoietin (EPO) (Semenza and Wang, 1992). At the time, EPO was known as a
glycoprotein hormone with the ability to stimulate erythrocyte production resulting in
increased oxygen delivery to hypoxic tissue. Later, HIF-1 was described to regulate the
transcription of the angiogenic protein vascular endothelial growth factor (VEGF)
(Forsythe et al., 1996). In addition to their classical roles, current research reveals that
both EPO and VEGF promote neurogenesis and act as neuroprotective factors (Ferriero,
2005).
1.4.1.2 HIF-1 regulation of cellular metabolism
Hypoxic cells, including cancer cells, shift their metabolism from mitochondrial
respiration to glycolysis within the cytosol. This shift results in glycolytic production of
ATP, the main cellular energy source. HIF-1 has been shown to regulate this shift from
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oxidative phosphorylation in the mitochondria to substrate-level phosphorylation in the
cytosol (Seagroves et al., 2001) and activate the transcription of genes that encode the
glucose transporters GLUT1 and GLUT3, as well as all of the enzymes involved in
glycolysis (Iyer et al., 1998; Seagroves et al., 2001; Lum et al., 2007; Semenza, 2010b).
Pyruvate, a product of glycolysis, can either be converted by the enzyme lactate
dehydrogenase A (LDHA) to lactate, or converted by pyruvate dehydrogenase (PDH) to
acetyl coenzyme A for entry into the tricarboxylic acid (TCA) cycle (Citric acid/Krebs
cycle). Conversion of pyruvate into lactate yields NAD+, which reenters glycolyis at the
level of glyceraldehyde-3-phosphate. HIF-1 upregulates the transcription of LDHA,
and lactate can be transported out of the cell by monocarboxylate transporter 4 (MCT4),
which is also transcriptionally upregulated by HIF-1(Semenza, 2010b). In addition,
HIF-1 transcriptionally upregulates pyruvate dehydrogenase kinase 1 (PDK1), which
phosphorylates and inactivates PDH. Inactivation of PDH shunts pyruvate away from the
mitochondria (Kim et al., 2006; Papandreou et al., 2006). Thus, HIF-1 has been shown
in cancer cells to essentially promote glycolysis and suppress mitochondrial respiration.
HIF-1 activity itself can be regulated by metabolic products and enzymes. For example,
loss-of-function of the TCA cycle enzymes succinate dehydrogenase, fumarate hydratase,
or isocitrate dehydrogenase alter the levels of the substrates succinate, fumarate, and ketoglutarate, respectively (Semenza, 2010b), which impair hydroxylation of HIF-1 and
stabilize it even under normoxic conditions. In addition, elevated levels of pyruvate and
lactate have been shown to inactivate prolyl hydroxylase domains resulting in
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stabilization of HIF-1 under normoxia, establishing a feed-forward mechanism for HIF1 stabilization (McFate et al., 2008).
1.4.1.3

HIF-1 regulation of NSPC differentiation

Hypoxia has been shown to promote the survival and proliferation of NSPCs grown in
culture (Morrison et al., 2000; Studer et al., 2000; Burgers et al., 2008; Santilli et al.,
2010), as well as other stem cell types (Gustafsson et al., 2005). In addition, hypoxia
prevents the ability of neural stem cells to differentiate, an effect mediated by Notch
signaling (Gustafsson et al., 2005). Activation of a Notch receptor (Notch 1-4) by one of
its ligands (Delta, Serrate, Lag-2) liberates the Notch intracellular domain (Notch ICD)
which translocates to the nucleus and interacts with the DNA binding protein Cpromoter-binding-factor (CSL). HIF-1 acts in a non-canonical fashion by binding to the
Notch ICD and promotes transcription of genes that regulate the undifferentiated
phenotype, including Hes and Hey (Simon and Keith, 2008).
In other cell types, hypoxia has also been shown to disrupt Wnt/-catenin signaling. Wnt
ligands are secreted glycoproteins that signal through Frizzled receptors to prevent
proteosomal degradation of intracellular -catenin. Stabilized -catenin translocates to
the nucleus and interacts with transcription factors (Tcf/Lef) to drive transcription of Wnt
target genes (Toledo et al., 2008). Signaling through Wnt/-catenin is required for
hippocampal neurogenesis (Lie et al., 2005) and stimulates NSPC differentiation toward
the neuronal lineage by upregulating the proneural transcription factor NeuroD1
(Kuwabara et al., 2009). In non-neuronal cells, HIF-1 binds to -catenin, thereby
inhibiting its transcriptional activity (Kaidi et al., 2007).
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1.5 Use of Nestin-CreERT2 mice for NSPC-specific Hif1a gene deletion
Systemic deletion of the Hif1a gene is embryonic lethal, associated with malformation of
the heart and cardiovascular system (Iyer et al., 1998). Conditional deletion of Hif1a
within nestin-positive stem cells of the developing nervous system results in
hydrocephalus, massive neuronal apoptosis, and regression of vasculature (Tomita et al.,
2003).

Therefore, we have utilized a tamoxifen-inducible Cre/loxP approach to

selectively knockout Hif1a gene expression in adult NSPCs within the context of the
adult brain. The use of the tamoxifen-inducible Cre/loxP system is a powerful approach
for studying NSPC-specific gene deletion or activation in cerebral ischemia (Battiste et
al., 2007; Burns et al., 2007). In this system, transgenic mice are generated that express
Cre recombinase fused with a tamoxifen-specific binding domain of a mutated estrogen
receptor (Cre-ERT2) (Hayashi and McMahon, 2002). Expression of the recombinase is
controlled by the nestin transcriptional promoter (Battiste et al., 2007; Lagace et al.,
2007). Cre recombinase is an enzyme from the P1 bacteriophage that acts in mammalian
cells to catalyze site-specific recombination between two of its 34-base pair recognition
elements, the loxP sites (Rossant and Nagy, 1995). This allows for precise excision of an
intervening sequence to functionally and conditionally activate or remove a gene of
interest (Nagy, 2000). The mutated estrogen receptor ligand binding domain, ERT2, does
not bind 17-estradiol at physiological concentrations, but is activated by the tamoxifen
metabolite 4-hydroxy (OH)-tamoxifen (TM). In the absence of tamoxifen, the Cre-ERT2
fusion protein is sequestered in the cytoplasm by Hsp90 binding to the estrogen receptor
domain, thereby preventing the movement of Cre recombinase into the nucleus and Cremediated excision of loxP DNA sequences. Binding of 4-OH-TM leads to a disruption of

16

the interaction with Hsp90, permitting access of Cre-ERT2 to the nucleus and initiation of
recombination (Figure 1.5).

NESTIN-CRE-TAMOXIFEN TRANSGENIC MICE
CR E

hsp90

+TM

CRE

CRE

ER T

CRE
ERT
TM

ERT
TM

Translocate to
Nucleus
LoxP –Stop- LoxP - YFP
CRE

Recombinase
active

YFP

Figure 1.5: Diagram depicting tamoxifen-mediated entry of Cre recombinase into the
nucleus, followed by DNA recombination and subsequent YFP expression.

Nestin-CreERT2 mice have been generated in which transgene expression is driven by the
nestin promoter to restrict Cre-ERT2 expression to nestin-positive stem cell populations,
providing both spatial and temporal control of recombinase activity, such that expression
of Cre recombinase is restricted to nestin-positive cells and is activated only in the
presence of tamoxifen. Nestin-CreERT2 mice were generated using 5.8kB of the nestin
promoter and exons 1-3, including the 2nd intronic enhancer, which confers neuralspecific expression, and not endothelial or pericyte expression (Lagace et al., 2007).
These mice have been crossed with the Rosa Cre-reporter mice, R26R-YFP, to generate
bitransgenic nestin-Cre-ERT2/R26R-YFP mice (Lagace et al., 2007). The R26R-YFP
allele contains a transcriptional ‘stop’ sequence flanked by 2 loxP sites (floxed) that
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intervenes between a constitutive transcriptional promoter and the YFP reporter
sequence, thereby preventing YFP reporter expression except in cells that harbor
activated cre-recombinase. Exposure of nestin-CreERT2/R26R-YFP mice to tamoxifen
activates Cre recombinase in nestin-positive cells, resulting in excision of the
transcriptional ‘stop’ sequence and transcriptional activation of YFP reporter gene
expression in nestin-positive NSPCs and all subsequent progeny.

As described in

Chapter 4 of this dissertation, we crossed this strain with mice that have floxed Hif1a
alleles, to generate nestin-Cre-ERT2/R26R-YFP/Hif1afl/fl triple transgenic mice in which
tamoxifen concomitantly activates YFP reporter expression and bi-allelic Hif1a gene
deletion in NSPCs of embryonic and postnatal brain.

1.6 Hypothesis and Specific Aims
Our laboratory is interested in the ability of NSPCs to survive sudden-onset hypoxia as
well as their contribution to repair processes following stroke (e.g. revascularization,
neuroprotection, and regeneration). The ongoing, long term goal of this research is to
elucidate molecular mechanisms that regulate NSPC survival and function under
ischemic conditions. For these studies, we isolated NSPCs from both embryonic and
postnatal brain, expanded them in culture and studied their responses to ischemic models
ex vivo. The overarching hypothesis of this dissertation is that hypoxia-inducible
factor-1 alpha (HIF-1) represents an intrinsic regulator of NSPC-mediated
neuroprotection, metabolism and survival during ischemic stress. We addressed this
hypothesis by completing the following Specific Aims.
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Specific Aim 1: To characterize the neuroprotective effects of NSPCs against
hypoxic injury. For these studies we investigated the ability of NSPCs to promote
neuronal survival under conditions of oxygen-glucose deprivation (OGD) in culture. We
found that NSPCs prevented cell death of cortical neurons in response to OGD, via HIF1-regulated release of vascular endothelial growth factor (VEGF). Chapter 2: Harms
KM, Li L, Cunningham LA. 2010. Murine neural stem/progenitor cells protect neurons
against ischemia by HIF-1-regulated VEGF signaling. PLoS ONE. 5:e9767.
Specific Aim 2: To elucidate the metabolic phenotype of NSPCs, and determine
whether HIF-1 regulates NSPC metabolism under normal and/or hypoxic
conditions. We utilized NSPCs from embryonic and adult mouse to determine the
relative dependence on glycolytic vs. oxidative metabolism for survival. These studies
demonstrated that NSPCs are primarily glycolytic and display minimal dependence on
mitochondrial oxidative phosphorylation. Hif1a gene deletion impaired the ability of
NSPCs to survive hypoxia, but did not increase the sensitivity of NSPCs to mitochondrial
toxins under normoxic conditions or reduce dependence on glycolytic metabolism.
Chapter

3:

Candelario

KM,

Shuttleworth

CW,

Cunningham

LA.

Neural

stem/progenitor cells display a glycolytic metabolic phenotype under normoxia. In
preparation for J. Neurochemistry. This work is also described in Chapter 4.
Specific Aim 3: To establish an in vivo model of targeted Hif1a gene deletion using
nestin-CreERT2/R26R-YFP/Hif1afl/fl mice.

We have established a triple transgenic

mouse colony, designated nestin-CreERT2/R26R-YFP/Hif1afl/fl, in which tamoxifen
administration results in concomitant activation of YFP expression and Hif1a gene

19

deletion. For these studies, we also established methods to characterize YFP expression
and Hif1a gene deletion in isolated NSPCs. This work is described in Chapter 4. This
work also contributed to a recent paper Li L, Harms KM, Ventura PB, Lagace DC,
Eisch AJ, Cunningham LA. 2010. Focal cerebral ischemia induces a multilineage
cytogenic response from adult subventricular zone that is predominantly gliogenic.
Glia 58:1610-1619.
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2.1 Abstract
Focal cerebral ischemia following middle cerebral artery occlusion (MCAO) stimulates a
robust cytogenic response from the adult subventricular zone (SVZ) that includes
massive proliferation of neural stem/progenitor cells (NSPCs) and cellular migration into
the injury area. To begin to explore beneficial roles of NSPCs in this response, we
investigated the ability of embryonic and postnatal NSPCs to promote neuronal survival
under conditions of in vivo and in vitro ischemia. Intracerebral transplantation of NSPCs
attenuated neuronal apoptosis in response to focal ischemia induced by transient MCAO,
and prevented neuronal cell death of cortical neurons in response to oxygen-glucose
deprivation (OGD) in culture.

NSPC-mediated neuroprotection was blocked by the

pharmacological inhibitors of vascular endothelial growth factor (VEGF), SU1498 and
Flt-1Fc. Embryonic and postnatal NSPCs were both intrinsically resistant to brief OGD
exposure, and constitutively expressed both hypoxia-inducible factor 1 (HIF-1)
transcription factor and its downstream target, VEGF. Genomic deletion of Hif1a by
Cre-mediated excision of exon 2in NSPC cultures resulted in >50% reduction of VEGF
production and ablation of NSPC-mediated neuroprotection. These findings indicate that
NSPCs promote neuronal survival under ischemic conditions via HIF-1-VEGF
signaling pathways and support a role for NSPCs in promotion of neuronal survival
following stroke.
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2.2 Introduction
Two predominant neurogenic regions persist within the adult mammalian brain, located
within the subgranular zone (SGZ) of the hippocampal dentate gyrus and the
subventricular zone (SVZ) surrounding the lateral ventricles (Eriksson et al., 1998; Gage,
2000; Doetsch, 2003a; Alvarez-Buylla and Lim, 2004). Neural stem/progenitor cells
(NSPCs) that reside within these brain regions are mitotically active, self-renewing cells
with the potential to differentiate into neurons, oligodendrocytes, or astrocytes (McKay,
1997; Gage, 2000; Temple, 2001; Ivanova et al., 2002).
Following focal cerebral ischemia, neural stem/progenitor cells (NSPCs) in the SVZ
proliferate and migrate to the lesioned site in both rodents and humans (Jin et al., 2001b;
Zhang et al., 2001; Arvidsson et al., 2002; Parent et al., 2002; Iwai et al., 2003; Jin et al.,
2006; Yamashita et al., 2006). Migration of NSPCs and their progeny may be critical for
post-ischemic repair, since ablation of progenitor proliferation leads to increased infarct
volume (Maysami et al., 2008) and the time course of this migratory response occurs
concomitant with partial spontaneous recovery of motor deficits (Kondziolka et al., 2000;
Zhang et al., 2005). Although hundreds of thousands of cells emigrate from the SVZ into
the injured striatal parenchyma, the number of neuroblasts that survive long-term
represents <0.2% of striatal neurons lost to ischemic injury (Kokaia et al., 2006). That
such a low number of new neurons contribute significantly to the reconstruction of
striatal circuitry seems unlikely. Nevertheless, evidence suggests that SVZ derivatives
migrating into the injured striatal parenchyma contribute importantly to the process of
endogenous wound healing following ischemic insult, through processes apart or in
addition to neuronal replacement (Burns et al., 2009). Additional mechanisms include
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stabilization of nascent vasculature following stroke-induced angiogenesis and/or
prevention of progressive neuronal cell loss via release of angiogenic and neurotrophic
factors.
Vascular endothelial growth factor (VEGF) is the most well-studied angiogenic factor,
but also has been shown to exert direct neurotrophic signaling and to promote adult
neurogenesis (Connolly et al., 1989; Jin et al., 2002; Ferrara, 2004). The most potent
inducer of VEGF gene expression is hypoxia (Shweiki et al., 1992). VEGF is
transcriptionally regulated by hypoxia-inducible factor-1 (HIF-1), which translocates
to the nucleus following hypoxia-induced stabilization, dimerizes with HIF-1 (ARNT),
and activates the hypoxia response element (HRE) in the promoter region of the VEGF
gene (for review see (Semenza, 2003)). VEGF is also regulated by HIF-independent
mechanisms including other transcription factors and co-activators (Arany et al., 2008)
(for reviews see (Mizukami et al., 2007; Birk et al., 2008)), micro-RNAs (Hua et al.,
2006), and inflammatory mediators (McColl et al., 2004). In neurons, VEGF mediates its
neurotrophic effects via the receptor tyrosine kinase, VEGFR-2 (Flk-1/KDR) (Jin et al.,
2002). Following stroke, exogenous administration of VEGF has been shown to reduce
infarct size and improve neurological performance (Sun et al., 2003). These effects are
thought to be due to both a direct neurotrophic action of VEGF on neurons and
stimulation of angiogenesis for re-establishment of blood flow following ischemic
damage.

Transgenic

mice

with

VEGF-overexpression

also

display

increased

neurogenesis, decreased infarct volume, and improved motor function (Wang et al.,
2007).
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Neural stem cells have previously been shown to provide neuroprotection when
transplanted into the adult brain in rodent models of stroke (Hayashi et al., 2006; Chu et
al., 2008; Jin et al., 2010b), raising the possibility that the endogenous SVZ response to
stroke may also provide neuroprotection of penumbral neurons at risk of delayed cell
death.

We have previously demonstrated that embryonic neural stem cells secrete

diffusible VEGF, which underlies their ability to protect endothelial cells against severe
ischemia and promote angiogenesis in ischemic striatum (Roitbak et al., 2008). In the
present study, we investigated whether embryonic or postnatal NSPCs also provide
neuroprotection against cerebral ischemia utilizing both in vitro and in vivo approaches.
Here, we demonstrate that both embryonic and postnatal NSPCs are robustly resistant to
oxygen-glucose deprivation (OGD), and provide neuroprotection under ischemic
conditions, an effect that is mediated by HIF-1-regulated release of diffusible VEGF by
primary NSPCs. These studies have important implications for both the therapeutic use
of exogenous NSPCs in stroke and also suggest a potential neuroprotective role for
endogenous NSPCs in adult brain repair.

2.3 Materials and Methods
2.3.1 Primary cortical neuronal and neural stem/progenitor cultures
Ethics Statement: This study was approved by the University of New Mexico Animal
Care and Use Committee and conformed to the NIH Guidelines for use of animals in
research. Timed pregnant female mice were sacrificed by isoflurane overdose and the
embryos removed by cesarean section. Primary neuronal cultures were established from
cerebral cortices of C57BL/6J embryos (The Jackson Laboratory, Bar Harbor, ME, USA)
at gestation day 15, using enzymatic dissociation with trypsin as previously described
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(Wetzel et al., 2008). For immunocytochemistry, 3.9 x 105 dissociated cells were plated
on poly-L-lysine-coated coverslips (0.1 mg/ml; Sigma, St Louis, MO, USA) in 24-well
plates. For biochemical procedures, 1.95 x 106 cells were plated on precoated poly-Llysine six-well plates (BD Biosciences, San Diego, CA, USA).

The cultures were

maintained under serum-free conditions in neurobasal medium (Invitrogen Corp.,
Carlsbad, CA, USA), supplemented with B-27 supplement (2%; Invitrogen Corp.),
glutamine (0.5 mM; Sigma), glutamate (25 μM; Sigma), penicillin (100 U/ml) and
streptomycin (100 μg/ml; Invitrogen Corp.). At 4 days in vitro (DIV), half of the medium
was removed and replaced with fresh medium without glutamate, as indicated by the
manufacturer. At 7 DIV, neuronal cultures were used for experimentation. Embryonic
neural stem/progenitor cells (eNSPC) were established from whole telencephalon of
EGFP-C57BL/6J embryos at gestation day 14 (E14), as described previously (Ray et al.,
1993). Postnatal NSPCs (pNSPC) were established from postnatal day 28 male EGFPC57BL/6J mice. NSPCs were plated on pre-coated poly-L-lysine six-well plates (BD
Biosciences). Growth factors were added every other day and cells were passaged at
least twice prior to use. NSPCs used for coculture were plated on 0.4 μM pore size
transwells (BD Biosciences) coated with poly-L-lysine (0.1 mg/mL; Sigma).

The

cultures were maintained under serum-free conditions in neurobasal medium (Invitrogen
Corp.), supplemented with B-27 supplement (2%; Invitrogen Corp.), glutamine (2.0 mM;
Sigma), penicillin (100 U/ml; Invitrogen Corp.), streptomycin (100 μg/ml; Invitrogen
Corp.), EGF (10 ng/mL; Invitrogen Corp.), and bFGF (10 ng/mL; Invitrogen Corp.). All
cultures were maintained in a humidified incubator at 37°C with 5% CO2. The cultures
were incubated with the following compounds: SU1498 (70 nM-50 μM; Calbiochem, San
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Diego, CA, USA), IgG-Fc (5 ng/mL-1 μg/mL; Jackson ImmunoResearch Laboratories,
West Grove, PA, USA), and Flt-1-Fc (5 ng/mL-1 μg/mL; R&D Systems, Minneapolis,
MN, USA).

2.3.2 Oxygen-glucose deprivation
Oxygen-glucose deprivation (OGD) was performed as previously described (Plesnila et
al., 2001; Wetzel et al., 2008). Primary cortical neuronal cultures and/or NSPCs were
placed in an anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA) containing a
gas mixture of 5% CO2, 5% H2 and 85% N2 (<0.2% O2). Normal culture media was
replaced with deoxygenated, glucose-free Earle's balanced salt solution, and the cultures
were maintained under glucose-free anaerobic conditions at 37°C for 2 h. OGD was
terminated by returning the cultures to normoxic conditions and neurobasal medium
supplemented with 2% B-27 supplement, 0.5 mM glutamine, 100 U/ml penicillin and
100 μg/ml streptomycin. As a control, sister cultures were placed in Earle's balanced salt
solution containing 25 mM glucose (Sigma) for 2 h at 37°C under normoxic (21% O2)
conditions and then returned under normoxic conditions to neurobasal medium
supplemented with 2% B-27 supplement, 0.5 mM glutamine, 100 U/ml penicillin and 100
μg/ml streptomycin.

2.3.3 Mild transient middle cerebral artery occlusion (MCAO)
Adult male C57BL/6J mice 20-25 g (The Jackson Laboratory) were housed under a 12 h
light: 12 h dark cycle with food and water available ad libitum. Mice (20-25 g; n=20)
were anesthetized with 4% isoflurane for induction and maintained on 1.0% isoflurane.
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The body temperature was maintained at 37oC with a heating pad. Mice were subjected to
30 minutes of transient MCAO as previously described(Kokovay et al., 2006). Briefly,
the right common carotid artery was exposed through a midline incision. The internal
carotid artery was isolated from external carotid artery which was ligated with 6-0 silk
suture. A 2-cm length of 6-0 rounded tip nylon suture was advanced from the common
carotid artery (CCA), through the internal carotid artery up to the level of the anterior
cerebral artery. The suture was inserted 10 to 11 mm from the bifurcation of CCA to
occlude the middle cerebral artery (MCA). After 30 min of MCAO, the suture was slowly
withdrawn to allow for reperfusion. Reperfusion time was 3 days post-MCAO. The mice
were anesthetized with sodium pentobarbital (150 mg/kg, Fort Dodge Animal Health,
Fort Dodge, IA, USA) administered intraperitoneally, and were transcardially perfused
first with preperfusing solution (0.01 mg/ml heparin and 1 mg/ml procaine) and
subsequently with 4% paraformaldehyde in 0.1 M phosphate buffered saline (PBS). The
brains were removed, post-fixed overnight in 4% paraformaldehyde, and cryoprotected
with 30% sucrose (w/v) in 0.1 M PBS for 48 hours at 4oC. For immunohistochemical
procedures (described below), the brains were sectioned at 30 m using a sliding
microtome (AO Scientific Instruments, Buffalo, NY, USA).

2.3.4 Embryonic NSPC transplantation
NSPCs isolated from E14 EGFP-expressing transgenic C57BL/6J mouse embryos were
expanded in culture as described above and transplanted into 8 week-old C57BL/6J
mouse striatum. Mice were anaesthetized with 2% isoflurane inhalation. Stereotaxic
injections were performed using Hamilton microsyringe with a 26-gauge blunt needle.
Each animal received an injection of 2.5 l (at the rate of 1 l /min, and concentration
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5x104 cells/l) of EGFP-NSPCs into the striatum (from bregma: A +1.0mm, L +2.0 mm,
V -2.6mm). To identify fragmentation of DNA characteristic of apoptosis, TUNEL
labeling was performed on paraformaldehyde fixed tissue from 30 minutes MCAO using
NeurotacsTM II kit (Trevigen, Inc, Gaithersburg, MD, USA), according to the
manufacturer’s protocol.

Tissue treated with TACs-nucleaseTM or without terminal

deoxynucleotidyl transferase served as positive and negative controls, respectively. NIH
ImageJ software was used to quantify TUNEL+ cells from fluorescent images using Sholl
analysis, with concentric rings placed at increasing distances (635 μm apart) around the
perimeter of the graft.

2.3.5 Immunohistochemistry
Cultured cells were fixed on coverslips with 4% paraformaldehyde and incubated in
monoclonal mouse anti-Nestin (1:500; Chemicon, Temecula, CA, USA), polyclonal
rabbit anti-MAP-2 (1:500; Chemicon), and/or polyclonal rabbit anti-GFAP (1:500;
Accurate, Westbury, NY, USA).

Histological sections (30 μm) were incubated in

monoclonal mouse anti-NeuN (1:1000, Chemicon) or polyclonal rabbit anti-MPO (1:500,
Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunofluorescence was visualized
using FITC- or Cy3-conjugated secondary antibodies (1:250; Jackson ImmunoResearch
Laboratories). DAPI nuclear stain was used to identify cell bodies of cultured cells
(Invitrogen Corp.). Immunofluorescence was analyzed using high-resolution confocal
microscopy (Zeiss LSM510, Thornwood, NY, USA) or conventional fluorescence
microscopy.
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2.3.6 Immunoassays
Soluble VEGF or BDNF were assayed from conditioned media using the Quantikine
Mouse Immunoassay for the appropriate protein (R&D Systems). HIF-1α was measured
in cell lysates using SurveyorTM IC Human/Mouse Total HIF-1α Immunoassay (R&D
Systems). Transcriptional activity of HIF-1 was measured in nuclear extract using the
TransAM HIF-1 kit (Active Motif, Carlsbad, CA, USA), substituting the primary
antibody for one that recognizes mouse (Novus Biologicals, Littleton, CO, USA).
Nuclear extracts used in this assay were isolated using the NE-PER Nuclear and
Cytoplasmic Extraction Reagent Kit (Pierce, Rockford, IL, USA). Absorbance for all
assays was read using a microplate reader (Dynex Technologies, Chantilly, VA, USA):
Quantikine assays were read at 450 nm with background subtraction of 570 nm;
TransAM assay was read at 450 nm with a background subtraction of 630 nm.

2.3.7 MTT cell viability assay
Cell viability was assessed using methylthiazolyldiphenyl-tetrazolium bromide (MTT)
dissolved in PBS (0.5 mg/mL; Sigma). Cultures were incubated with MTT at 37оC for 4
hr. Formazan crystals were solubilized using 1:1 ethanol:DMSO solution. Absorbance
was measured at 570 nm with a background subtraction of 630 nm.

2.3.8 Hif1a gene deletion from NSPCs
NSPCs were isolated from embryonic day 14 transgenic mice containing loxP-flanked
exon 2 of the Hif1a gene (Hif1afl/fl) (Ryan et al., 2000) that were crossed to the C57BL/6J
background (The Jackson Laboratory). NSPCs were passaged twice prior to 48 hr
treatment with an adenovirus expressing Cre-recombinase (Ad-CMV-Cre; Vector
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Biolabs, Philadelphia, PA, USA) at 50 MOI (multiplicity of infection). This method
recombines the DNA between the two loxP sites to excise the intervening sequence.
Twenty-four hours after infection, NSPCs were passaged twice more before used in
experiments. To confirm deletion of exon 2 of the Hif1a gene, DNA was isolated and
efficiency of cre-recombination was detected with PCR using forward primer 5’- TGT
TAA ATA AAA GCT TGG AC -3’ and reverse primer 5’- GCA GTT AAG AGC ACT
AGT TG -3’ (Milosevic et al., 2007). Successful DNA recombination yields Hif1a genedeleted NSPCs (HIF-1Δ/Δ), as indicated by the loss of the 1200 bp band amplification
product and appearance of a 250 bp band. Experiments using HIF-1Δ/Δ eNSPCs were
compared to wild-type C57BL/6J eNSPCs treated similarly with Ad-CMV-Cre.

2.3.9 Statistical Analyses
Data are expressed as means + S.E.M. Significant differences between means were
determined by student’s t-test or analysis of variance (ANOVA) with Tukey multiple
comparisons post hoc analysis using Prism software (Graphpad Software, San Diego,
CA, USA). P values < 0.05 are considered statistically significant.

2.4 Results
2.4.1 NSPCs provide neuroprotection against focal ischemia in vivo.
To determine whether mouse NSPCs are neuroprotective in our animal model of focal
ischemia, we isolated embryonic NSPCs from transgenic mice that express enhanced
green fluorescent protein (EGFP) under the -actin promoter.

We have previously

demonstrated that these NSPCs fulfill the criteria of multi-potentiality and self-renewal
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(Roitbak et al., 2008). EGFP-NSPCs were expanded in culture and subsequently
transplanted into the right dorsal striatum of adult recipient mice. Control mice received
vehicle injections of phosphate buffered saline only.

Seventy-two hours following

transplantation, recipients were subjected to an ipsilateral transient middle cerebral artery
occlusion (MCAO) for 30 minutes, followed by three days of reperfusion. As shown in
Figure 2.1 A, MCAO resulted in a robust apoptotic response at three days as assessed by
TUNEL labeling of injured striatum in vehicle treated mice. EGFP-NSPC recipients
displayed >50% fewer TUNEL+ nuclei compared to vehicle controls (Figure 2.1 B),
particularly in the area immediately surrounding the graft and extending out to at least 4.5
mm from the graft border (Figure 2.1 E,F).

Conversely, healthy appearing NeuN+

neuronal nuclei were numerous near the graft, whereas control mice displayed
widespread loss of NeuN+ cells (Figure 2.1 C,D). These data demonstrate robust NSPCmediated neuroprotection against focal ischemia in the MCAO model. We previously
reported that NSPC-transplant promotes vascularization and proliferation of blood
vessels within the ischemic striatum (Roitbak et al., 2008), suggesting an effect of NSPCs
on the vasculature. Activated neutrophils, as identified by myeloperoxidase (MPO)
staining, were not observed in either vehicle- or NSPC-injected striatum, suggesting that
NSPC transplantation does not alter the inflammatory response following stroke (Figure
2.7). To test whether NSPCs have a direct effect on neurons during ischemia, we shifted
to an in vitro cell culture system using a well-characterized OGD model (Plesnila et al.,
2001).
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2.4.2 NSPCs provide neuroprotection against OGD and are intrinsically resistant to in
vitro ischemia.
We utilized a transwell coculture paradigm to begin to delineate the mechanisms
underlying NSPC-mediated neuroprotection. NSPCs and cortical neurons were cultured
separately as monocultures or were cocultured in separate compartments of porous
transwells (0.4 μm pore size), which allowed for sharing of conditioned media but did not
allow cell-cell contact between NSPCs and neurons seeded in the upper vs. lower
compartments, respectively. As shown in Figure 2.2, cortical cultures contained MAP-2+
neurons, with minimal contamination by GFAP+ astrocytes, and NSPC cultures were
uniformly immunopositive for the stem cell marker, nestin. Neuronal and NSPC cultures
were subjected to control or OGD conditions for 2 hours and assessed for cell viability 24
hr later using an MTT assay. As shown in Figure 2.2 B, cortical cultures underwent
approximately 40% cell loss within 24 hr following OGD, as previously described
(Wetzel et al., 2008), but only ~12% cell loss when cocultured with NSPCs. Importantly,
NSPC monocultures were robustly resistant to 2 hour OGD and displayed no significant
cell loss at 24 hours (Figure 2.2 C). These data indicate that NSPCs provide robust
neuroprotection of cortical neurons in culture via diffusible substance(s), and are
themselves resistant to OGD conditions.

2.4.3 Diffusible VEGF is responsible for NSPC-mediated neuroprotection against OGD.
HIF-1 is a key mediator of the adaptive cellular response to hypoxia and acts through
transcriptional and non-transcriptional pathways to regulate the activities of genes
involved in cell survival and angiogenesis, including VEGF. As shown in Figure 2.3 A,
NSPC monocultures constitutively expressed HIF-1 and displayed a nearly 3-fold
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increase in HIF-1 expression measured 24 hr following a 2 hr exposure to OGD. In
contrast, HIF-1 was not measurable in neuronal monocultures under nonhypoxic
conditions or at 24 hr following a 2 hr OGD exposure (not shown). As shown in Figure
2.3 B, both neuronal and NSPC monocultures constitutively expressed the HIF-1 target
gene, VEGF, and released VEGF into the culture media.

VEGF release was not

statistically different in cortical monocultures following OGD, but was increased 2.5-fold
in NSPC monocultures as measured 24 hr following 2 hr exposure to OGD. Culture
media from NSPCs was also used to measure the presence of brain-derived neurotrophic
factor (BDNF), however BDNF was undetected in both control and OGD-exposed NSPC
media (data not shown).
To

determine

whether

diffusible

VEGF

is

responsible

for

NSPC-mediated

neuroprotection, neurons in monoculture or in transwell coculture with NSPCs were
exposed to OGD in the presence or absence of the VEGFR2 kinase inhibitor, SU1498 (10
M; Figure 2.4 A) or the VEGF decoy receptor, Flt-1-Fc (1.0 g/ml; Figure 2.4 B) added
at the onset of OGD and present for 24 hr thereafter. As demonstrated in Figure 2.4 A,
SU1498 had no effect on neuronal viability under non-ischemic conditions, but
completely inhibited the ability of NSPCs to provide neuroprotection against OGD in
coculture. Prevention of VEGF-VEGFR interaction at the cell surface with Flt-1-Fc also
impaired the neuroprotection provided by cocultured NSPCs (Figure 2.4 B). Doseresponse analysis for both SU1498 and Flt-1-Fc showed that neither compound was
cytotoxic to neurons in monoculture at the concentration used in this study (Figure 2.8).
Exposure of neuronal cultures to NSPC-conditioned media resulted in significant
neuroprotection against OGD, an effect that was also blocked by SU1498 and Flt-1-Fc
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inhibition of VEGF signaling (Figure 2.4 C). Flt-1-Fc was not cytotoxic to NSPCs, and
had no effect on the ability of NSPCs to withstand OGD conditions (Figure 2.9). These
data indicate that NSPC-mediated neuroprotection is mediated by diffusible VEGF and
dependent on neuronal VEGFR signaling.

2.4.4 Gene deletion of Hif1a impairs NSPC-mediated neuroprotection.
To determine the extent to which endogenous NSPC HIF-1 governs VEGF expression
and NSPC-mediated neuroprotection, eNSPCs were isolated from transgenic mice that
harbor loxP sites flanking exon 2 of the Hif1a gene at both alleles (Hif1afl/fl) (Ryan et al.,
2000). Hif1awt/wt and Hif1afl/fl NSPC cultures were incubated for 24 hr with adenovirus
harboring a bacterial Cre-recombinase gene sequence to confer Cre expression (AdCMV-Cre). As shown in Figure 2.5 A, transduction of NSPC cultures with Ad-CMVCre resulted in excision of Hif1a exon 2 in Hif1afl/fl NSPCs (Hif1a), but not in
Hif1awt/wt NSPCs, as indicated by PCR analysis of genomic DNA isolated 24 hr
following removal of Ad-CMV-Cre. HIF-1 transcriptional activity was completely
abolished as assessed by the inability of nuclear extract proteins to bind the hypoxia
response element (HRE) in Hif1a cells, but not in Hif1awt/wt cells (Figure 2.5 B). Hif1a
gene deletion in NSPCs also resulted in a 50% reduction of VEGF release by Hif1a
NSPCs compared to Hif1awt/wt NSPCs in response to anoxia (Figure 2.5 C). Hif1a gene
deletion had no effect on NSPC survival at 24 hr following 2 hr OGD (96.8 % + 8.5 %
vs. 101.6 % + 6.7 %, Hif1awt/wt vs. Hif1a, respectively, ns, n=4; Figure 2.10), but
abrogated the neuroprotective effects of NSPC conditioned media (Figure 2.5 D). Thus,
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HIF-1 appears to be necessary for NSPC-mediated neuroprotection since media from
Hif1a cultures failed to protect neurons from OGD-induced death.

2.4.5 Postnatal NSPCs are neuroprotective, resistant to ischemia and constitutively
express stabilized HIF-1 and VEGF.
To determine whether postnatal NSPCs also confer neuroprotection and are resistance to
in vitro ischemia, we isolated NSPCs from postnatal day 28 mouse SVZ and expanded
the pNSPCs in culture using the same paradigm as for eNSPCs. As shown in Figure 2.6
(A and B), pNSPCs constitutively expressed stabilized HIF-1 and VEGF at levels
similar to eNSPCs under non-ischemic conditions, with robust induction of both proteins
in response to 24 hr anoxia. pNSPCs also displayed resistance to 2 hr OGD exposure
(Figure 2.6 C), and media conditioned by pNSPCs provided neuroprotection against 2 hr
OGD (Figure 2.6 D).

2.5 Discussion
In this study, we investigated the neuroprotective effects of embryonic and postnatal
NSPCs under conditions of ischemia, and the role of HIF-1-regulated VEGF signaling
in this process. We found that exogenous NSPCs protect neurons against focal ischemic
injury induced by MCAO in vivo, and protect embryonic cortical neurons against OGD
exposure in culture. In contrast to primary cortical neurons, NSPCs display intrinsic
resistance to brief 2 hr OGD exposure in culture, and constitutively express stabilized
HIF-1 and its downstream target, VEGF. Pharmacological blockade of VEGF signaling
in culture impairs neuroprotection, and Hif1a gene deletion in NSPCs results in both
impaired VEGF production and impaired neuroprotection against OGD.
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These

observations provide evidence that NSPCs promote neuronal survival under conditions of
ischemia via HIF-1-regulated VEGF signaling and suggest that NSPCs may play a
neuroprotective role following stroke.
VEGF is recognized as both a vasculotrophic factor and a neurotrophic factor. VEGF
expression in the brain is downregulated in early postnatal life after formation of the
cerebral vasculature is complete, but becomes upregulated in adult brain in response to
stroke or mechanical injury (Kovacs et al., 1996; Krum and Rosenstein, 1998; Marti and
Risau, 1999). Administration of exogenous VEGF following stroke results in reduced
neuronal cell death, increased angiogenesis and increased vascular permeability (Zhang
et al., 2000; Sun et al., 2003; Greenberg and Jin, 2005) (reviewed in(Carmeliet and
Storkebaum, 2002; Greenberg and Jin, 2005; Hansen et al., 2008)). VEGF also exerts a
direct neuroprotective effect against in vitro ischemia, mediated by neuronal VEGFR2
signaling and downstream activation of the phosphatidylinositol 3-kinase (PI3
kinase)/Akt pathway in cultured neurons (Jin et al., 2000; Jin et al., 2001a; Ogunshola et
al., 2002; Rosenstein et al., 2003; Kilic et al., 2006; Taoufik et al., 2008). Our studies
suggest that VEGF release by NSPCs underlies in vitro neuroprotection against ischemia,
via direct activation of neuronal VEGFR2 receptors, since neuroprotection was abrogated
by the presence of the VEGFR2 kinase inhibitor, SU1498, and by the presence of the
VEGFR decoy receptor, Flt-1-Fc. In conjunction with our previous report (Roitbak et al.,
2008), VEGF could have a dual effect in the graft: improved revascularization and direct
neuroprotection.
VEGF production by both embryonic and adult NSPCs in culture has previously been
reported (Madhavan et al., 2008; Roitbak et al., 2008; Teng et al., 2008; Wang et al.,
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2008). NSPC expression of VEGF is known to be upregulated in response to hypoxic
and metabolic stress (Madhavan et al., 2008; Roitbak et al., 2008). Our present study
demonstrates that cortical cultures also release diffusible VEGF under normoxic
conditions but do not display increased VEGF production at 24 hr following 2 hr OGD,
whereas VEGF release by NSPCs is increased 2-3 fold within 24 hr post-OGD.
Although inhibition of VEGFR2 signaling blocks NSPC-mediated neuroprotection,
inhibition of VEGFR2 signaling has no impact on the survival of neurons under
normoxic conditions, and has no effect on the ability of NSPCs to survive ischemic
insult. These observations suggest that increased VEGF production by NSPCs underlies
neuronal protection against in vitro ischemia, but does not mediate NSPC resistance to
ischemic conditions and is not required for survival of cortical neurons under normoxic
conditions.
One of the most potent regulators of VEGF expression is HIF-1. HIF-1 is primarily
regulated at the post-translational level, with protein stability dependent upon pO2. In
most mammalian cell types, HIF-1 protein is hydroxylated under normoxic conditions,
binds the von Hippel-Lindau (VHL) protein, and is rapidly degraded by the 26S
proteosome.

Under conditions of hypoxia, HIF-1 is not hydroxylated and rapidly

accumulates to enter the nucleus and dimerize with HIF-1 (ARNT), forming the HIF-1
transcriptional complex that regulates target genes through cis-acting hypoxia response
elements (HREs). In most cell types Hif1a mRNA is constitutively transcribed and
translated, but the protein only has a half-life of less than 5 minutes under non-hypoxic
conditions (for review, see (Semenza, 2003; Weidemann and Johnson, 2008)). Our
observation that HIF-1 is constitutively stabilized by cultured NSPCs, even at 21% O2,
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suggests that NSPCs may also utilize a non-oxygen dependent mechanism for
maintaining HIF-1 stability and that HIF-1 plays a fundamental role in NSPC
homeostasis under both normoxic and hypoxic conditions. Previous studies have
demonstrated O2-independent stabilization of HIF-1 by heat shock protein 90 (HSP-90)
through binding the PAS domain of HIF-1 (Isaacs et al., 2002). HSP-90 has also been
shown to be involved in the regulation of HIF-1 stability in embryonic mesencephalic
NSPCs (Xiong et al., 2009).
While the role of constitutive HIF-1 stabilization in NSPCs is not completely
understood, HIF-1 is recognized as a multifunctional protein that regulates the
expression and activity of multiple genes involved in angiogenesis, glucose metabolism,
proliferation and self-renewal, apoptosis, and migration through both transcriptional and
non-transcriptional signaling pathways (Bergeron et al., 1999; Bernaudin et al., 1999;
Gustafsson et al., 2005; Chen et al., 2009). Others have shown that upregulation of HIF1 in neural progenitor cells enhances their ability to survive in vitro and following
transplantation (Theus et al., 2008), as well as provide neuroprotection against ischemia
(Chu et al., 2008). In addition to VEGF, HIF-1 is a potent inducer of erythropoietin
(EPO), which promotes neurogenesis, NSPC proliferation and neuroprotection following
ischemia (Bernaudin et al., 1999; Shingo et al., 2001; Tsai et al., 2006; Chen et al.,
2007b). However, neural-specific EPOR knockdown does not increase infarct volume
following focal cerebral ischemia and therefore endogenous levels of EPO may not
provide neuroprotection following stroke (Tsai et al., 2006). Conversely, antisense
blockade of VEGF in vivo results in an enlargement of infarct volume caused by transient
MCAO (Yang et al., 2002). In the present study, we found that Hif1a gene deletion
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results in >50% reduction of VEGF production and a concomitant impairment of
neuroprotective activity in NSPC-conditioned medium. However, these data also indicate
that VEGF production is at least partially regulated by HIF-1-independent mechanisms
in NSPCs, since Hif1a gene deletion did not completely block VEGF production.
We previously demonstrated that embryonic NSPCs protect endothelial cells against
ischemia-induced damage and stimulate increased endothelial cell proliferation via HIF1-regulated VEGF signaling mechanisms (Roitbak et al., 2008). Here, we extend those
studies to demonstrate that NSPCs also provide neuroprotection through similar signaling
mechanisms. While neural stem cells were initially recognized as potential therapeutic
agents for stroke and neurodegenerative disease based on their potential to replace lost
neurons and integrate into host circuitry, our studies support the possibility that the
therapeutic potential of neural stem cells may lie predominantly in their ability to
promote endogenous brain repair processes. Following stroke, NSPCs and their progeny
migrate to the lesioned area and inhibition of this migration leads to an increase in infarct
size (Maysami et al., 2008). Our study reveals that NSPCs may directly protect against
ischemic injury through the release of diffusible VEGF. Further studies will require
NSPC-targeted gene deletion of Vegf and Hif1a to delineate the role of endogenous
NSPCs in neuroprotection in vivo, as well as their effects on other cell types within the
neurovascular niche. While in vitro modeling is crucial to understanding the molecular
mechanisms of the interactions between neurons and NSPCs, in vivo studies will account
for the ischemic microenvironment.
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While our studies suggest that NSPCs themselves are neuroprotective and important for
vascular remodeling following stroke, care must be taken with development of
therapeutical strategies. Direct NSPC transplantation into the post-ischemic environment
may lead to graft overgrowth and tumor formation due to their pluripotency and ability to
self-renew (Seminatore et al., 2010). While VEGF infusion may look promising,
injection of recombinant human VEGF has been shown to promote blood vessel
permeability as well as blood-brain barrier leakage (Zhang et al., 2000). Thus, elucidating
the mechanisms by which NSPCs protect the ischemic penumbra following stroke will
provide novel therapeutic strategies for facilitating the contribution of endogenous
NSPCs for brain repair.

2.6 Figure Legends
Figure 2.1: NSPCs protect against 30 minute MCAO. (A-D) Coronal histological
sections through the ischemic striatum 3 days following MCAO, stained for TUNEL
(A,B) or NeuN (C,D). Mice received intrastriatal injections of exogenous PBS (A,C) or
EGFP+NSPCs (B,D,E) 72 hr prior to MCAO. Inset in (B) shows 40X magnified view of
the injection site. (E) Monochrome conversion of image shown in B to demonstrate
concentric ring structures used for Sholl analysis. (F) Quantification of TUNEL+ cells
using Sholl analysis performed on fluorescent images. *p<0.05, n=5 mice per group.
Scale bar: A,B = 20 m; C,D = 10 m.
Figure 2.2: NSPCs provide neuroprotection against OGD and are resistant to in
vitro ischemia. (A) Diagram of transwell coculture. Micrograph depicts cortical neurons
in lower compartment immunofluorescently labeled for MAP-2 (red) and GFAP (green).
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NSPCs in upper compartment are immunofluorescent for nestin (red). Nuclei are labeled
with DAPI (blue). (B) Neuronal survival at 24 hrs following 2 hr exposure to OGD in the
absence (left) or presence (right) of NSPCs. (C) Survival of NSPCs grown as
monocultures in upper compartment. Data were acquired using the MTT colorimetric
viability assay as described in methods section. *p<0.01, Student’s t-test, n=4
cultures/group.

Figure 2.3: HIF-1 and VEGF expression in eNSPC cultures under control vs. OGD
conditions. (A) HIF-1 protein levels in cell lysates from eNSPCs at 24 hrs following a
2 hr exposure to OGD or control conditions. (B) VEGF within neuronal or NSPC
conditioned media following 2 hr exposure to control or OGD conditions. Media was
conditioned for 24 hrs following exposure to OGD or control conditions. *p<0.05,
Student’s t-test, n=4 cultures/group.

Figure

2.4:

Pharmacological

inhibition

of

VEGF

signaling

impairs

the

neuroprotective effects of eNSPCs. (A,B) Neuronal viability 24 hrs following exposure
to 2 hr OGD vs. control conditions in the presence or absence of NSPCs and the VEGFR
kinase inhibitor, SU1498 (A) or the VEGF receptor decoy receptor, Flt-1-Fc (B). (C)
Neuronal viability in the presence or absence of NSPC-conditioned media and SU1498 or
Flt-1Fc. *p<0.05, n=4 cultures/group.
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Figure 2.5: Gene deletion of Hif1a impairs neuroprotective ability of eNSPC. (A)
PCR amplification products from genomic DNA isolated from wild-type and Hif1afl/fl
NSPCs exposed to 50 MOI Ad-CMV-Cre for 48 hrs. Excision of exon 2 from Hif1a
gene is indicated by the shorter band at 250 bp, present after Ad-CMV-Cre exposure of
Hif1afl/fl but not wild-type NSPCs. (B) Transcriptional activity of HIF-1 in wild-type
vs. Hif1a NSPCs assayed by HRE binding assay. (C) VEGF in 24 hr conditioned
media from wild-type vs. Hif1a NSPCs. (D) Viability of cortical cultures 24 hr
following 2 hr OGD in the presence or absence of wild-type vs. Hif1a NSPCs CM.
*p<0.05, n= 4 cultures/group.

Figure 2.6: Postnatal NSPCs are neuroprotective and resistant to ischemia. (A) HIF1 protein levels in cell lysates and (B) VEGF concentration in conditioned medium
from pNSPCs at 24 hr following 2 hr exposure to control or OGD conditions. (C)
Viability of pNSPCs at 24 hr post-OGD. (D) Viability of cortical neuronal cultures 24 hr
following 2 hr OGD in the presence of neuronal vs. pNSPC conditioned medium.
*p<0.05, n=4 cultures/group.

Figure 2.7: Myeloperoxidase (MPO) staining for activated neutrophils. (A-D)
Myeloperoxidase (MPO) staining of coronal histological sections through the ischemic
striatum 3 days following MCAO. Mice received intrastriatal injections of exogenous
EGFP+NSPCs (A-C) or PBS (D) 72 hr prior to MCAO. Scale bar: 10 m.
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Figure 2.8: Dose-response of neurons to SU1498 and Flt-1-Fc. Neurons were exposed
to increasing concentrations of the VEGFR2 inhibitor SU1498 (A) or the decoy VEGFR1
Flt-1-Fc (B). SU1498 was cytotoxic at concentrations of 50 and 100 M, but not at 10
M which was the dose used in our experiments (A). A toxic dose of Flt-1-Fc was not
determined (B).

Figure 2.9: NSPC response to inhibition of autocrine VEGF. Embryonic NSPCs were
exposed to the VEGFR1 decoy Flt-1-Fc (1 g/mL). Flt-1-Fc did not impair the viability
of eNSPCs, and did not impair their ability to survive OGD.

Figure 2.10: NSPC viability in response to 2 hr OGD. Deletion of exon 2 of the Hif1a
gene did not impair eNSPC ability to survive 2 hr OGD, as compared to wild-type
eNSPCs.
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Figure 2.1: NSPCs protect against 30 minute MCAO.
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Figure 2.2: NSPCs provide neuroprotection against OGD and are resistant to in vitro ischemia.
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Figure 2.3: HIF-1 and VEGF expression in eNSPC cultures under control vs. OGD conditions.
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Figure 2.4: Pharmacological inhibition of VEGF signaling impairs the neuroprotective effects of
eNSPCs.
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Figure 2.5: Gene deletion of HIF-1 impairs neuroprotective ability of eNSPC.
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Figure 2.6: Postnatal NSPCs are neuroprotective and resistant to ischemia.
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Figure 2.7: Myeloperoxidase (MPO) staining for activated neutrophils.
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Figure 2.8: Dose-response of neurons to SU1498 and Flt-1-Fc.
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Figure 2.9: NSPC response to inhibition of autocrine VEGF.

53

Figure 2.10: NSPC viability in response to 2 hr OGD.
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3.1 Abstract
Neural stem/progenitor cells (NSPCs) of the subventricular zone (SVZ) lie in a niche in
close contact with the vasculature. In vitro, NSPCs thrive under low oxygen tensions.
Whether progenitors in the SVZ live in a hypoxic niche in vivo remains to be determined,
but it is becoming increasingly apparent that oxygen tension influences embryonic and
adult neural stem/progenitor cell properties.

Very little is known concerning the

bioenergetics of NSPCs, and determining their metabolic phenotype may assist in
understanding basic stem cell properties as well as NSPC response to metabolic insults.
To explore the metabolic phenotype of NSPCs in culture, we investigated the ability of
embryonic and postnatal NSPCs to survive prolonged hypoxia and metabolic inhibition.
NSPCs were compared to mature cortical neurons known to depend on oxidative
metabolism. We show that NSPCs survive 24 h anoxia but are readily injured by glucose
depletion.

In addition, NSPCs were unable to utilize substrates for mitochondrial

metabolism, but relied on both glycolysis and the pentose phosphate pathway in the
cytosol. Conditioned media from cultured NSPCs contained elevated lactate production
as well as elevated intracellular LDH activity compared to neuronal cultures. NSPCs
displayed decreased oxygen consumption rate and increased extracellular acidification
rate compared to neurons.

Taken together, these data indicate that NSPCs utilize

glycolysis under normoxic conditions and display a different metabolic phenotype
compared to differentiated neurons.

56

3.2 Introduction
Neural stem cells are multipotent cells with self-renewing capabilities.

During

embryonic development radial glial cells within the ventricular zone serve as primitive
neural stem cells that give rise to both neuronal and glial lineages (for review, see
(Kriegstein and Alvarez-Buylla, 2009)). Neural stem cells derived from embryonic radial
glia persist throughout adulthood within restricted regions that include the forebrain
subventricular zone (SVZ) and hippocampal dentate subgranular zone (SGZ), where they
continue to give rise to new neurons and glia of the adult olfactory bulb and dentate
gyrus, respectively (Eriksson et al., 1998; Gage, 2000; Doetsch, 2003a, b; Alvarez-Buylla
and Lim, 2004).

Although the role of adult neurogenesis in normal brain function

remains controversial, the potential therapeutic use of neural stem cells to replace
damaged neurons and glia within the adult central nervous system is an area of intense
research and clinical significance. Therapeutic approaches include transplantation of
neural stem cells that have been expanded in an undifferentiated state ex vivo, and
manipulation of endogenous neural stem cells that are resident within the adult brain.
The therapeutic significance of understanding neural stem cell biology is also
underscored by a potential link with CNS cancer stem cells, which share many properties
with normal adult neural stem cells (Germano et al., 2010; Mohyeldin et al., 2010).
Finally, neural stem cells of the adult brain display a remarkable capacity to withstand
many types of metabolic and traumatic brain injuries as well as mount an endogenous
regenerative response (Lichtenwalner and Parent, 2006), making them attractive targets
for promoting structural and functional brain repair.
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It is becoming increasingly apparent that oxygen levels have a profound effect on the
stem cell niche and strongly influence the proliferation, self-renewal, and phenotypic fate
choice of neural stem cells during normal development and disease (Csete, 2005; Simon
and Keith, 2008; Panchision, 2009). Low oxygen tension promotes self-renewal of
neural stem cells in culture and the preferential development of certain cell types upon
differentiation (Morrison et al., 2000; Studer et al., 2000; Chen et al., 2007a; Pistollato et
al., 2007; Burgers et al., 2008; Horie et al., 2008; Santilli et al., 2010). Disruption of
oxygen availability by perinatal hypoxia/ischemia (Yang and Levison, 2006, 2007) or
following stroke in adulthood (Arvidsson et al., 2002; Thored et al., 2006; Li et al., 2010)
stimulates increased proliferation of cells within the SVZ and re-directed migration of
SVZ-derivatives into the hypoxic brain region. In culture, neural stem/progenitor cells
(NSPCs) are relatively resistant to brief periods of oxygen-glucose deprivation (OGD)
when compared to primary cortical neurons (Roitbak et al., 2008; Harms et al., 2010),
which are highly dependent upon oxidative metabolism for survival (Pellerin et al.,
2002). Although studies have demonstrated that neural stem cells thrive under low
oxygen conditions in cell culture (Morrison et al., 2000; Studer et al., 2000; Santilli et al.,
2010), very little is known concerning the bioenergetics of NSPCs or how metabolic
homeostasis is regulated in these cells. Such processes are, however, fundamental for
maintenance of the neural stem/progenitor cell pool and neural stem/progenitor cell
survival following a metabolic insult such as cerebral ischemia and stroke.
Much evidence indicates that adult stem cells from various tissues, embryonic stem cells
derived from the inner cell mass of the blastocyst, and cancer stem cells all share
common aspects of metabolic phenotype defined by high glycolytic flux, low oxygen
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consumption, and minimal dependence on mitochondrial oxidative phosphorylation for
ATP synthesis and survival (Chung et al., 2007; Lonergan et al., 2007; Kang et al., 2009;
Panchision, 2009; Prigione et al., 2010). This form of metabolism is thought to underlie
self-renewal and maintenance of the undifferentiated phenotype (Smith et al., 2000;
Diehn et al., 2009). In the present study, we investigated the metabolic phenotype of
embryonic and adult neural stem/progenitor cells (NSPCs) by testing their relative
dependence on glycolysis vs. mitochondrial oxidative phosphorylation for survival.

3.3 Materials and Methods
3.3.1 Primary cell culture
This study was approved by the University of New Mexico Animal Care and Use
Committee and conformed to the NIH Guidelines for use of animals in research. Timed
pregnant female mice were sacrificed by isoflurane overdose and the embryos removed
by cesarean section.
3.3.1.1 NSPC cultures
Neural stem/progenitor cells (NSPCs) were isolated from embryonic day 14.5 (E14.5) or
from postnatal day 28 (PD28) C57BL/6J mice (The Jackson Laboratory, Bar Harbor,
ME, USA). Embryonic NSPCs (eNSPC) were established from whole telencephalon as
previously described (Ray et al., 1993; Harms et al., 2010). Postnatal NSPCs (pNSPC)
were established from the microdissected SVZ of PD28 male C57BL/6J mice using
described protocols (Babu et al., 2007; Smrt et al., 2007; Li et al., 2008) in conjunction
with the MACS Neural Tissue Dissociation Kit (Miltenyi Biotec, Auburn, CA, USA).
Following dissociation, NSPCs were plated in six-well tissue culture plates pre-coated
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with poly-L-lysine (BD Biosciences) or on poly-L-lysine-coated glass coverslips within
24-well culture plates at a density of 3.125 x 104 cells/cm2. The cultures were maintained
under serum-free conditions in Neurobasal medium (Invitrogen) supplemented with B-27
supplement (2%; Invitrogen), glutamine (2.0 mM; Sigma), penicillin (100 U/ml;
Invitrogen), streptomycin (100 μg/ml; Invitrogen), epidermal growth factor (EGF; 10
ng/mL; Invitrogen), and basic fibroblast growth factor (bFGF; 10 ng/mL; Invitrogen)
(Ray et al., 1993; Wachs et al., 2003). Growth factors (EGF and bFGF) were added
every other day and cells were passaged at least twice prior to use. These cultures have
been previously shown to be uniformly nestin-positive and to undergo spontaneous
differentiation into neurons and glia after growth factor withdrawl (Roitbak et al., 2008;
Harms et al., 2010).
3.3.1.2 Cortical neuron cultures
Primary neuronal cultures were established from cerebral cortices of C57BL/6J embryos
at gestation day 15.5 (E15.5), using enzymatic dissociation with trypsin as previously
described (Wetzel et al., 2008; Harms et al., 2010). For cell viability assays, 3.9 x 105
dissociated cortical cells were plated on poly-L-lysine-coated coverslips (0.1 mg/ml;
Sigma, St Louis, MO, USA) in 24-well plates (2.0 x 105 cells/cm2). For biochemical
procedures, 1.95 x 106 cells were plated on precoated poly-L-lysine six-well plates (2.0 x
105 cells/cm2; BD Biosciences, San Diego, CA, USA). The cultures were maintained
under serum-free conditions in Neurobasal medium (Invitrogen Corp., Carlsbad, CA,
USA), supplemented with B-27 supplement (2%; Invitrogen Corp.), glutamine (0.5 mM;
Sigma), glutamate (25 μM; Sigma), penicillin (100 U/ml), and streptomycin (100 μg/ml;
Invitrogen Corp.). At 4 days in vitro (DIV), half of the medium was removed and
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replaced with fresh medium without glutamate. At 7 DIV, neuronal cultures were used
for experimentation. All cultures were maintained in a humidified incubator at 37°C with
5% CO2.

3.3.2 Glucose or Oxygen Deprivation
3.3.2.1 Glucose deprivation
NSPC or neuronal cultures were deprived of glucose for 24 h by replacing culture media
(25 mM glucose) with glucose- and pyruvate-free Neurobasal media (Invitrogen),
supplemented with B-27 supplement (2%; Invitrogen Corp.), glutamine (0.5 mM;
Sigma), glutamate (25 μM; Sigma), penicillin (100 U/ml) and streptomycin (100 μg/ml;
Invitrogen Corp.), with or without added pyruvate (1.0-20 mM; Sigma) as indicated. For
colorimetric assays (see below), phenol red-free Neurobasal media was used (Invitrogen).
3.3.2.2 Oxygen deprivation
For oxygen deprivation, primary NSPCs or cortical neuronal cultures were placed in an
anaerobic chamber (Coy Laboratories, Grass Lake, MI, USA) containing a gas mixture of
5% CO2, 5% H2, and 85% N2 (<0.2% O2) for 24 h. Normal culture media was replaced
with deoxygenated culture media (Invitrogen). Media was supplemented as described
above for the appropriate cell type. Sister cultures placed at 37°C under normoxic (21%
O2) conditions served as non-hypoxic negative controls. Cell viability was normalized to
non-hypoxic controls in all experiments.

3.3.3 Pharmacological Treatments
NSPC or neuronal cultures were exposed for 24 h to the following compounds, added
directly to the culture media: sodium cyanide (CN; 0.01-2.0 mM; Sigma), rotenone (0.161

100

M;

Sigma),

oligomycin

(Sigma;

0.5-10

M),

carbonyl

cyanide

4-

(trifluoromethoxy)phenylhydrazone (FCCP; 0.5-10 M; Sigma), 2-deoxy-D-glucose (2DG; 10 mM; Sigma), galactose (25 mM; Sigma), dichloroacetate (DCA; 500 M;
Sigma), and 6-aminonicotinamide (6-AN; 1-1000 M; Sigma). Figure 3.1 depicts the
metabolic pathways targeted by each of these drugs.

3.3.4 MTT cell viability assay
Cell viability was assessed using methylthiazolyldiphenyl-tetrazolium bromide (MTT)
dissolved in PBS (0.5 mg/mL; Sigma) as described (Harms et al., 2010). Cultures were
incubated with MTT at 37оC for 4 hr. In anaerobic cultures, the MTT solution was
equilibrated to anoxia prior to addition to the culture wells. Formazan crystals were
solubilized using 1:1 ethanol:DMSO solution. Absorbance was measured at 570 nm with
a background subtraction of 630 nm.

3.3.5 Lactate dehydrogenase (LDH) and lactate colorimetric assays
For all colorimetric assays, NSPC or neuronal cultures were incubated in phenol red-free
culture media for 24 h prior to assay measurements. Intracellular lactate dehydrogenase
(LDH) activity was measured using the CytoTox96® Non-Radioactive Cytotoxicity
Assay (Promega Corporation, Madison, WI, USA), according to the manufacturer
protocol, and absorbance measured at 490 nm. Lactate concentration was measured in
culture media using the colorimetric assay protocol from the Lactate Assay Kit
(BioVision, Mountain View, CA, USA), and absorbance was measured at 570 nm. LDH
and lactate measurements were normalized to protein using the MicroBCA kit (Pierce,
Rockford, IL, USA).
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3.3.6 Respiration and medium acidification rates
To monitor oxygen consumption and glycolysis in real time, we utilized a Seahorse
Bioscience XF24 multiwell extracellular flux analyzer (Seahorse Bioscience, North
Billerica, MA). The Seahorse XF24 instrumentation is a highly sensitive 24-well format
for measuring oxygen consumption and medium acidification (rate of glycolysis). The
XF24 utilizes a specialized 24-well culture plate, to allow for lowering an array of
sensors to enclose a 7 l fluid volume above a layer of attached cells in each well.
Oxygen consumption rate (OCR) and medium extracellular acidification rate (ECAR) are
monitored by fluorescence probes immobilized in matrices attached to the sensor and are
measured in near real time over several hours at 37oC.
To compare oxygen consumption and glycolytic rates of neurons vs. NSPCs, embryonic
cortical neurons or embryonic NSPCs were plated onto 24-well XF cell culture plates
(Seahorse Bioscience) coated with poly-L-lysine (0.1 mg/mL; Sigma). Neurons were
plated at a density of 1.95 x 105 cells/cm2 and utilized after 7 days in vitro (DIV), with
one-half media change at 4 DIV. eNSPCs were plated at a density of 6.0 x 105 cells/cm2
and used at 3 DIV when they reached confluency. The XF sensor cartridge was loaded
into the Seahorse analyzer following the manufacturer’s instructions. All experiments
were performed at 37oC with starting volume of 675 L/well of DMEM containing 5 mM
glucose (Sigma), 1mM pyruvate (Invitrogen), and 1 mM glutamine (Sigma).
Mitochondrial inhibitors and vehicles were administered to all wells in a volume of 75
L each/well via automated injector ports.

Final concentrations of mitochondrial

inhibitors were as follows: oligomycin (1 M), FCCP (5 M), and rotenone (1 M).
Each oxygen consumption and acidification rate data point represents one measurement
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averaged over 2-3 wells. One measurement cycle is comprised of a mixing time of 3
minutes, followed by a wait time of 2 minutes, and a data acquisition period of 4 minutes.
Data points established for the OCR/ECAR graph (Figure 3.6 C) are the mean of four
measurement cycles per treatment group. At the end of the experiment, protein levels for
each cell type were determined by the MicroBCA kit (Pierce). All oxygen consumption
rates and acidification rates were normalized per g protein/well.

3.4 Results
3.4.1 NSPCs require glucose for survival and are resistant to 24 hours of anoxia
We previously demonstrated that both embryonic and postnatal NSPCs survive 2-3 h
oxygen-glucose deprivation (OGD) (Roitbak et al., 2008; Harms et al., 2010), whereas
embryonic cortical neurons undergo significant cell death (Wetzel et al., 2008; Harms et
al., 2010). To determine the relative dependence of NSPCs on oxygen vs. glucose
availability for survival, we compared the viability of NSPCs following 24 h exposure to
oxygen (<0.2% O2) or glucose deprivation using an MTT cell viability assay. As shown
in Figure 3.2 A, NSPCs survived 24 h anoxia in the presence of 25 mM glucose, but were
unable to withstand 24 h glucose deprivation even under normoxic conditions. Glucose
deprivation resulted in >75% cell loss under normoxia and >90% loss under anoxia. That
NSPCs survive anoxia, but not glucose deprivation, suggests that NSPCs can rely more
on glycolysis than on oxidative phosphorylation for survival.

3.4.2 NSPCs are resistant to pharmacologic inhibition of mitochondrial electron transport
Glucose serves as a primary metabolic substrate for the generation of ATP. Glycolysis is
the anaerobic arm of glucose metabolism, and occurs within the cytosol to generate 2
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molecules ATP per molecule of glucose.

Oxidation of the glycolytic end product

pyruvate occurs within the mitochondria via electron transfer and oxidative
phosphorylation to generate up to 36 molecules of ATP per molecule of glucose (Vander
Heiden et al., 2009).
To determine whether NSPCs require mitochondrial oxidative phosphorylation for
survival, we exposed both embryonic NSPCs (eNSPC) and postnatal NSPCs (pNSPC) to
pharmacological inhibitors of mitochondrial electron transport for 24 h under normoxic
conditions.

Primary cortical neurons, known to be highly reliant on oxidative

phosphorylation for survival, served as a positive control for mitochondrial toxicity.
3.4.2.1 Complex I, IV, and V inhibition
As shown in Figure 3.2 B, neuronal cultures experienced approximately 75% cell loss
following 24 h exposure to the complex IV inhibitor, cyanide (1.0 mM), whereas NSPCs
displayed no appreciable loss in cell viability (Figure 3.2 B). Exposures up to 2.0 mM
cyanide also resulted in no significant loss of NSPC viability, although neuronal cell
death reached a maximal level at the lowest dose of 0.5 mM cyanide (Appendix Figure
A1 A). To rule out the possibility that NSPC resistance to cyanide may be due to a short
half-life of cyanide in culture media, we replaced the culture media containing fresh
cyanide (1 mM) at 8 and 20 hours. Addition of cyanide three times to culture media
decreased the number of viable eNSPCs by approximately 40% and neuronal survival by
90% (Figure 3.2 C). Both eNSPCs and pNSPCs also displayed relative resistance to the
Complex V ATP synthase inhibitor, oligomycin (Figure 3.2 D; 1.0 M), and to the
complex I inhibitor, rotenone (Figure 3.2 E; 1 M). Dose response curves for oligomycin
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and rotenone are presented in the Appendix (Figure A1 B and C). Interestingly, pNSPCs
displayed the greatest resistance to mitochondrial inhibition.

3.4.2.2 Mitochondrial electron transport chain-oxidative phosphorylation uncoupling
We next tested the sensitivity of neurons and eNSPCs to the uncoupler, FCCP (carbonyl
cyanide 4-(trifluoromethoxy)phenylhydrazone).

Ionophores such as FCCP uncouple

mitochondrial electron transfer from oxidative phosphorylation (ATP synthesis) by
creating electrical short circuit across the mitochondrial membrane. This stimulates
oxygen consumption in an attempt to re-establish the proton gradient, slows
mitochondrial ATP synthesis, which is reliant on a proton-motive force, and depletion of
mitochondrial ATP and consumption of cytoplasmic ATP as complex V activity begins
to run in reverse. As anticipated, FCCP treatment for 24 h resulted in a dose-dependent
decrease in viability of both neurons and eNSPCs (Figure 3.3 A). However, concomitant
exposure to oligomycin (0.5 M) partially rescued eNSPCs, but not neurons, from FCCP
toxicity. As shown in Figure 3.3 B, eNSPC cultures exposed to FCCP (5 M) in the
presence of oligomycin (0.5 M) displayed a 14% increase in survival compared to
treatment with FCCP alone (p<0.05). Oligomycin blockade of reversed ATP synthase
activity prevents depletion of cytosolic ATP during FCCP treatment. The differential
ability of oligomycin to rescue NSPCs, but not neurons, from FCCP toxicity suggests that
NSPCs are more heavily reliant on cytosolic ATP production for survival.
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3.4.3 NSPCs are reliant on glycolysis for energy metabolism and survival
3.4.3.1 Glycolytic inhibition with pyruvate replacement
To further explore the extent to which NSPCs are reliant on the anaerobic glycolytic arm
of glucose metabolism for energy production and survival, NSPCs were grown under
conditions of glycolytic inhibition in the presence or absence of the mitochondrial TCA
substrate, pyruvate. Glycolytic inhibition was achieved by glucose deprivation combined
with the glycolytic inhibitor 2-deoxy-D-glucose (2-DG; 10 mM). 2-DG is a competitive
substrate for hexokinase phosphorylation; however, unlike glucose, phosphorylated 2-DG
cannot be further metabolized, leading to its accumulation and blockade of the glycolytic
arm of glucose metabolism (Pelicano et al., 2006). The glycolytic end product, pyruvate,
is a primary mitochondrial oxidation substrate for ATP synthesis through oxidative
phosphorylation, and can substitute for glucose in cells dependent upon mitochondrial
oxidative phosphorylation for survival. Therefore we tested whether NSPCs could be
rescued from glycolytic inhibition by pyruvate replacement (0.1-20 mM) for 24 h under
normoxic conditions. As shown in Figure 3.4 A, primary cortical neurons were rescued
from glycolytic inhibition by the TCA substrate pyruvate in a dose-dependent manner,
whereas NSPCs underwent loss of viability following glycolytic inhibition independent
of the presence of pyruvate (up to 20 mM) (Figure 3.4 A).
3.4.3.2 Inhibition of the pentose phosphate pathway
2-DG treatment not only blocks glycolysis, but also inhibits the pentose phosphate
pathway (hexose monophosphate shunt) which requires glucose-6-phosphate to drive
nicotinamide adenine dinucleotide phosphate (NADPH) production as well as generate
important metabolic intermediates for macromolecule synthesis (Pelicano et al., 2006).
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Proliferating cells require this pathway to generate biomass in preparation for production
of a daughter cell (Vander Heiden et al., 2009). Although production of ATP through
glycolysis is inefficient compared to complete metabolism of glucose through the TCA
cycle and the electron transport chain, previous studies have demonstrated that highly
proliferative cells have a relatively low ATP requirement but a tremendous glucose
requirement to provide substrate for the pentose phosphate pathway (Vander Heiden et
al., 2009). Shunting of glucose-6-phosphate from glycolysis toward the pentose pathway
is achieved by glucose-6-phosphate dehydrogenase (G6PD), which converts glucose-6phosphate to 6-phosphogluconolacetone. To determine whether NSPCs are reliant on the
pentose phosphate pathway, G6PD was inhibited with 6-aminonicotinamide (6-AN; 100
M; Figure 3.4 B), in the presence of glucose under normoxic conditions.

As

anticipated, NSPC survival was significantly impaired in the presence of 6-AN treatment
compared to neurons, indicating NSPCs rely on the pentose phosphate pathway for
survival and/or continued proliferation. A dose-response curve for 6-AN is presented in
the Appendix (Figure A1 D).
3.4.3.3 Galactose replacement
To simultaneously maintain substrate for the pentose phosphate pathway and inhibit
glycolysis, we substituted galactose for glucose in the culture medium. Galactose can be
converted to glucose-6-phosphate via the Leloir pathway, but this reaction occurs too
slowly for ATP synthesis to be maintained and forces use of glutamine as an energy
source for mitochondrial metabolism (Weinberg and Chandel, 2009).

Glutamine is

converted to glutamate, which in turn is converted to -ketoglutarate, a TCA cycle
intermediate.

Thus, substituting galactose for glucose tends to drive mitochondrial
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respiration while keeping the pentose phosphate shunt relatively intact (Weinberg and
Chandel, 2009). For these experiments, eNSPCs were exposed to 25 mM galactose and 1
mM pyruvate in the absence of glucose for 24 h at normoxia. As shown in Figure 3.4 C,
eNSPC viability was decreased by >60% when galactose was provided as an alternative
substrate. These results indicate that NSPCs are dependent upon glycolysis for survival
and can not utilize pyruvate or glutamine as alternate substrates.
3.4.3.4 Inhibition of pyruvate dehydrogenase kinase (PDK)
In most oxidative cell types, pyruvate is converted to acetyl coenzyme A (acetyl-CoA)
via the mitochondrial enzyme, pyruvate dehydrogenase, which is in turn regulated by the
pyruvate dehydrogenase inhibitor, pyruvate dehydrogenase kinase (PDK). In glycolytic
cell types, PDK phosphorylates and thereby inhibits pyruvate dehydrogenase to shunt
pyruvate away from mitochondrial TCA metabolism (Semenza, 2010b).

To determine

whether increased PDK activity may be responsible for shunting pyruvate from
mitochondrial toward cytosolic metabolism, we treated NSPCs with the pyruvate
dehydrogenase kinase inhibitor dicholoroacetate (DCA; 500 M) (Bonnet et al., 2007).
However, exposure to DCA did not render NSPCs sensitive to cyanide toxicity (500 M;
Figure 3.4 D), indicating that blocking PDK activity does not result in a metabolic shift
toward mitochondrial respiration in these cells. Taken together, these data suggest that
NSPCs rely on glycolysis and that pharmacological manipulation cannot force a
metabolic shift toward mitochondrial respiration.
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3.4.4 Lactate production and LDH activity are upregulated in NSPC cultures
Cells that rely heavily on glycolysis vs. mitochondrial oxidative phosphorylation for
energy production shunt pyruvate toward lactate production and thereby display high
enzymatic activity of lactate dehydrogenase (LDH). Conversion of pyruvate to lacate via
LDH also results in increased production of NAD+, which feeds back into the glycolytic
pathway at the level of glyceraldehyde-3-phosphate to ensure a high rate of glycolytic
flux. To determine whether NSPCs display increased lactate production under normoxic
conditions, we measured lactate within 24 h eNSPC-conditioned media and measured
LDH activity within these cells. As shown in Figure 3.5 A and B, both lactate production
and LDH activity were 1.5- and 2-fold higher in NSPCs compared primary cortical
neurons, respectively. These data are consistent with a high rate of glycolytic flux in
NSPCs under normoxic conditions.

3.4.5 eNSPCs diplay diminished mitochondrial respiratory capacity and reduced Pasteur
effect compared to neurons following mitochondrial inhibition
3.4.5.1 Oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
To further explore the metabolic phenotype of eNSPCs, we performed a mitochondrial
stress test to compare the mitochondrial profile of eNSPCs to that of neurons. Using the
XF-24 metabolic flux analyzer (Seahorse Bioscience), we measured the oxygen
consumption rate (OCR) and extracellular acidification rate (ECAR) at baseline and in
the presence of mitochondrial inhibitors. Baseline OCR was similar in both cultures, and
addition of oligomycin (1.0 M) did not reduce OCR, indicating a higher dose of
oligomycin is required to distinguish the percent of oxygen consumption devoted to ATP
production versus the amount devoted to maintenance of the proton gradient (Figure 3.6
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A). To estimate the maximal respiratory capacity of the mitochondria, FCCP (5 M) was
added and resulted in a dramatic increase in OCR in both cell types (Figure 3.6 A). The
maximal respiratory capacity of neurons was greater than eNSPCs (188.9% ± 9.6% vs.
154.8% ± 9.8% of baseline, respectively, p<0.05).

The addition of the complex I

inhibitor rotenone (1 M) resulted in a further reduction of OCR values for both neurons
and eNSPCs (13.48% ± 1.62% vs. 15.21% ± 2.56% of baseline, respectively, data not
significant). Addition of rotenone, however, did not significantly alter ECAR in eNSPC
cultures over baseline (109.7% ± 9.7%) yet decreased the ECAR of neurons to 38.01% ±
1.51% of baseline, indicating an ability of eNSPCs to utilize glycolysis regardless of
mitochondrial function (Figure 3.6 B).
3.4.5.2 OCR/ECAR ratios
The ratio of OCR to ECAR provides insight as to whether a cell type is primarily
glycolytic or oxidative. Plotting OCR as a function of ECAR, and setting up an arbitrary
grid between the basal levels for each cell type, one can visualize that eNSPCs appear
more glycolytic than neurons (Figure 3.6 C).

In general, OCR/ECAR readings for

eNSPCs are more toward the lower right quadrant, indicating that they are more
glycolytic and less aerobic than neurons. Addition of FCCP reveals that eNSPCs have a
maximal respiratory capacity with a lower OCR and a higher ECAR than neurons, and
addition of rotenone shows that eNSPCs maintain increased ECAR compared to neurons.
Taken together, the mitochondrial stress test reveals that eNSPCs are more glycolytic
than neurons.
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3.4.5.3 Structural integrity of mitochondria
Diminished respiratory capacity could be due to reduced number or reduced function of
mitochondria in NSPCs. To determine whether NSPCs harbor mitochondria, cells were
stained using MitoTracker® Red (Invitrogen) which accumulates in active mitochondria
based on the membrane potential. As shown in the Appendix (Figure A2 A), NSPCs
appeared to contain mitochondria.

Furthermore, transmission electron microscopy

(TEM) revealed elongated mitochondria within NSPCs with reasonably developed cristae
structure (Figure A2 B). Thus reduced respiratory capacity does not appear to be due to
the absence of mitochondria, or to underdeveloped cristae structure. Reduced respiratory
capacity in NSPCs vs. neurons should also be reflected by differences in mitochondrial
density, which were not quantified in this study.

3.5 Discussion
Understanding the metabolic phenotype of neural stem cells is important not only for
fundamental cell biology, but also for understanding how these cells respond to metabolic
insults. Despite this, very little was known of the metabolic requirements of neural stem
cells. Previous studies have indicated that many stem cell types, including neural stem
cells, thrive under low oxygen conditions, yet the metabolic underpinnings of these
effects had remained largely unexplored. Here, we have investigated the metabolic
phenotype of both embryonic and adult neural stem/progenitor cells in culture and
demonstrate that these cells rely on glycolysis for survival, even under conditions of
normoxia, and are relatively insensitive to mitochondrial metabolic toxins. Furthermore,
we demonstrate that NSPCs cannot be rescued from glycolytic inhibition by providing
alternative energy substrates such as glutamine or pyruvate, but do require the pentose
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phosphate pathway. These studies provide insight into metabolic regulation in NSPCs
and may provide important clues for understanding NSPC survival under pathologic
metabolic insult.
We found that eNSPCs and pNSPCs are resistant to mitochondrial inhibitors of oxidative
phosphorylation. Interestingly, pNSPCs were more resistant than eNSPCs. This seems
surprising since eNSPCs would be expected to be adapted to the relative hypoxic
environment of the embryo, which develops in an environment containing 3% O2 before
the circulatory system is established (Mitchell and Yochim, 1968; Rodesch et al., 1992;
Fischer and Bavister, 1993; Simon and Keith, 2008). Our studies, therefore, indicate that
eNSPCs and pNSPCs are not identical in sensitivity to mitochondrial toxins. Although
relatively resistant, both embryonic and postnatal NSPCs eventually succumb to
mitochondrial toxins at high concentrations. Since these experiments were performed in
the presence of oxygen, it is possible that toxicity at high concentrations could be due to
free radical formation. Flux through the electron transport chain leads to the formation of
reactive oxygen species (ROS) which can cause cell death through damage to proteins,
lipids, and nucleic acids (Saretzki et al., 2004; Lee and Wei, 2005). Further experiments
testing these toxins under conditions of anoxia could help to resolve this issue.
Interestingly, free radical formation can not only act as a toxic agent to kill highly
proliferative cells (Seyfried and Shelton, 2010), but is also involved in cell signaling and
differentiation (Tsatmali et al., 2006).

Cultured NSPCs proliferate rapidly due to

stimulation with epidermal growth factor (EGF), which selects for the transient
amplifying progenitor cell population of the SVZ that divides rapidly in vivo (Doetsch et
al., 1997; Riquelme et al., 2008). We found that NSPCs could not be forced to rely on
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mitochondrial respiration. Although electron transport and oxidative phosphorylation is
the most efficient pathway for the generation of ATP, it is also a producer of ROS.
Reactive oxygen species are not only toxic to proliferating cells, but ROS production
(e.g. superoxide and hydrogen peroxide) can also signal differentiation of certain stem
cell types including both cardiac stem cells (Puceat, 2005) and NSPCs (Tsatmali et al.,
2006).

As neuronal differentiation proceeds, higher levels of ROS are produced

compared to the undifferentiated phenotype (Tsatmali et al., 2005).

Cellular

differentiation appears to be coupled with a shift in cellular metabolism from glycolysis
to oxidative phosphorylation (Piccoli et al., 2005; Chung et al., 2007; Chen et al., 2008),
which is likely to underly the shift in ROS production and ROS signaling as well. Thus
mitochondrial function may be inextricably linked to maintaining stem cell phenotype
through limiting ROS signaling and subsequent differentiation.
The degree of stemness appears to be correlated with bioenergentic function, with stem
cell populations displaying glycolysis and differentiated cells utilizing oxidative
phosphorylation (Piccoli et al., 2005; Chung et al., 2007; Chen et al., 2008). Our studies
suggest that as NSPCs differentiate into post-mitotic neurons, there is a switch towards
oxidative phosphorylation to drive synthesis of ATP, possibly due to a maturation of the
mitochondria.

However, EM analysis shows that NSPCs have normal appearing

mitochondria and do not appear immature.

Therefore, the lack of mitochondrial

respiration is not due to a lack of mature mitochondria with normal cristae structure. In
contrast, primitive stem cell types such as embryonic stem cells derived from the
blastocyst, as well as adult stem cells such as cardiac stem cells, display low oxygen
consumption coupled with mitochondria harboring poorly developed cristae structure
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(Sathananthan et al., 2002; Perez-Terzic et al., 2003; Sturmey and Leese, 2003; Chung et
al., 2007).
The high glucose requirement of NSPCs may explain their anatomical proximity to blood
vessels in vivo, which would ensure an abundance of glucose. While one molecule of
glucose is sufficient to generate more than enough ATP required by a proliferating cell,
several molecules of glucose are required to generate the NADPH necessary for sufficient
nucleotide and fatty acid synthesis (Vander Heiden et al., 2009). Cell division by the
progenitor population requires biomass to create a daughter cell. Therefore the majority
of glucose consumed by the cell is used to produce a daughter cell such that its
conversion to glucose-6-phosphate is shunted toward nucleotide synthesis via the pentose
phosphate pathway. It is via the pentose phosphate pathway that NADPH is produced
(Vander Heiden et al., 2009). NSPC need for glucose may be related to their high rate of
proliferation, balanced by a relatively minimal ATP requirement.
Shunting of the glycolytic product pyruvate away from the mitochondria results in
increased lactate production. The conversion of pyruvate to lactate by the enzyme lactate
dehydrogenase also yields NAD+, an electron acceptor that can be fed back into the
cytosolic glycolytic pathway at the level of glyceraldehyde-3-phosphate and reduced by
glyceraldehyde-3-phosphate dehydrogenase. Interestingly, lactate production has also
been shown to facilitate cell migration via modification of the extracellular matrix (e.g.
increased acidification of the extracellular matrix by lactate production in cancer cells has
been shown to facilitate metastasis) (Schlappack et al., 1991; Gatenby and Gillies, 2004).
Lactate can also serve as a neuronal energy source (Bouzier-Sore et al., 2003), which
raises the possibility of NSPC-neuron metabolic coupling similar to that of astrocytes.
75

Dependence upon glycolysis under aerobic conditions has been termed the Warburg
effect, and is a predominant feature of many cancer cell types (Gatenby and Gillies,
2004). The mechanisms that drive glycolysis in the presence of oxygen are not entirely
clear. Growth factor signaling, tyrosine kinase activity, and PI3K/Akt activity have been
shown to upregulate the glycolytic phenotype through modulation of glycolytic enzymes,
as well as stimulation of glucose uptake and utilization (Vander Heiden et al., 2009).
Several studies have also suggested that constitutive expression of stabilized hypoxiainducible factor-1 (HIF-1) drives the glycolytic phenotype in many types of cancer
cells.

HIF-1is a transcription factor that regulates the transcription of glycolytic

enzymes in cancer cells, including the glucose transporters GLUT1 and GLUT3, lactate
dehydrogenase, and all of the enzymes involved in glycolysis (Semenza, 2010b). We
have previously demonstrated that NSPCs express constitutive HIF-1 stabilization in
culture, through mechanisms that are not completely understood (Roitbak et al., 2008;
Harms et al., 2010). Other studies have shown that HIF-1 is important in maintaining
the undifferentiated phenotype of other stem cell types (Simon and Keith, 2008), but
whether HIF-1 is driving the glycolytic phenotype under aerobic conditions in NSPCs
has not yet been demonstrated (see Chapter 4).
Our work described here, together with other studies, demonstrate that low oxygen
environments promote the survival and proliferation of NSPCs grown in culture
(Morrison et al., 2000; Studer et al., 2000; Burgers et al., 2008; Santilli et al., 2010). In
the adult mouse, brain tissues range from 0.5-8% O2 and are said to be at “physiological
hypoxia” compared to the surrounding atmosphere containing 21% O2 (Zhu et al., 2005).
However, NSPCs reside within a highly vascularized niche (Tavazoie et al., 2008) and it
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is thus difficult to assume that these cells are oxygen-deficient. Never-the-less, the
primitive metabolic phenotype of NSPCs may indeed underlie their ability to withstand a
precipitous decline in oxygen tension under conditions of pathological hypoxia, e.g.,
following cerebral infarction.

3.6 Figure Legends
Figure 3.1: Diagram of metabolic inhibition. Glucose metabolism occurs in the
cytosol via glycolysis and the pentose phosphate pathway. Pyruvate can be shunted into
the mitochondria, where cellular metabolism occurs via the TCA cycle within the
mitochondrial matrix and electron transport across the inner mitochondrial membrane.
Media supplements used in this study are depicted in the color red. Glycolytic inhibitors
include 2-deoxy-D-glucose (2-DG) and galactose.
inhibited by 6-aminonicotinamide (6-AN).

The pentose phosphate shunt is

Dichloroacetate (DCA) inhibits pyruvate

dehydrogenase kinase (PDK) to allow increased activity of pyruvate dehydrogenase
(PDH). Electron transport chain inhibitors include rotenone, cyanide, and oligomycin.
FCCP is a protonophore that uncouples the oxidation of NADH from the phosphorylation
of ADP within the electron transport chain.
Figure 3.2: NSPCs survive anoxia and do not require electron transport. (A) MTT
colorimetric viability assay of embryonic NSPCs exposed to 24 h oxygen and/or glucose
deprivation. (B-D) MTT colorimetric viability assay of neurons, eNSPCs, and pNSPCs
with 24 h exposure to mitochondrial inhibitors at normoxia: (B-C) cyanide, (D)
oligomycin, (E) rotenone. Experiments depicted in B, D, and E were treated with the
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inhibitor one time. For figure 3.2 C, cells were treated with cyanide 3 times. n=4 per
treatment group. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001.
Figure 3.3:

NSPCs utilize cytosolic production of ATP.

(A) MTT colorimetric

viability assay of neurons and eNSPCs in response to 24 h incubation with increasing
concentrations of the ionophore FCCP (0.5-10 M) at normoxia. (B) MTT colorimetric
viability assay of neurons and eNSPCs in the presence or absence of oligomycin (0.5
M) and/or FCCP (5 M). n=4 per treatment group. *p<0.05.
Figure 3.4: NSPCs do not utilize mitochondrial respiration and rely on the pentose
phosphate shunt. (A-B) MTT colorimetric viability assay of neurons and eNSPCs at
normoxia following 24 h treatment in the presence of: (A) 2-DG (10 mM) plus pyruvate
(0.1-20 mM), (B) 6-aminonicotinamide (6-AN; 100M), or (C) galactose (25 mM). (D)
MTT colorimetric viability assay of eNSPCs incubated for 24 h at normoxia with cyanide
(500 M) and/or DCA (500 M). n=4 per treatment group. **p<0.001. ***p<0.0001.
Figure 3.5: LDH activity and lactate production are elevated in NSPC cultures. (C)
Intracellular LDH activity in neurons and eNSPCs. (D) Lactate concentration in the
media of neuron and eNSPC cultures. n=4 per treatment group. *p<0.05. ***p<0.0001.
Figure 3.6: NSPCs display decreased maximal respiratory capacity and increased
extracellular acidification compared to neurons.

Measurement of (A) oxygen

consumption rate (OCR), (B) extracellular acidification rate (ECAR), and (C) OCR to
ECAR ratio of neurons vs. eNSPCs at baseline and in the presence of oligomycin (oligo;
1.0 M), FCCP (5M), and rotenone (1 M). n=2-3 per treatment group.
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Figure A1: Dose-response curves of neurons and eNSPCs in the presence of cellular
respiration inhibitors: (A) cyanide (0.1-2 mM), (B) oligomycin (1-10 M), (C)
rotenone (0.1-100 M), and (D) 6-aminonicotinamide (6-AN; 1-1000 M).
Figure A2: Visualization of mitochondria using (A) MitoTracker Red staining or (B)
transmission electron microscopy.

For immunocytochemistry in (A), NSPCs were

identified using an antibody against nestin (green).
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Figure 3.1: Diagram of metabolic inhibition.
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Figure 3.2: NSPCs survive anoxia and do not require electron transport
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Figure 3.3: NSPCs utilize cytosolic production of ATP
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Figure 3.4: NSPCs do not utilize mitochondrial respiration and rely on the pentose phosphate shunt
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Figure 3.5: LDH activity and lactate production are elevated in NSPC cultures
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Figure 3.6: NSPCs display decreased maximal respiratory capacity and increased extracellular
acidification compared to neurons
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4.1 Abstract
We have shown previously that hypoxia-inducible factor-1 (HIF-1 protein is
stabilized in neural stem/progenitor cells (NSPCs) in vitro at normoxia and upregulated
with exposure to hypoxia. We have also determined that NSPCs utilize glycolysis under
normoxic conditions and are not affected by mitochondrial inhibition. To investigate the
role of HIF-1 in NSPC viability and metabolism, we generated a conditional and
inducible transgenic mouse model to specifically ablate expression of Hif1a from nestinpositive NSPCs. Administration of tamoxifen to nestin-CreERT2/R26R-YFP/Hif1afl/fl
mice results in complete deletion of the Hif1a gene from NSPCs. Experimentation on
embryonic and postnatal NSPCs cultured from these mice reveal that HIF-1 is required
for the ability of NSPCs to withstand 24 h anoxia, but does not regulate the glycolytic
metabolic phenotype. These studies implicate a role for HIF-1 in NSPCs as well as
provide a useful tool for examining this role in vivo.
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4.2 Introduction
Embryonic and adult neural stem/progenitor cells (NSPCs) express low levels of
constitutively stabilized hypoxia-inducible factor-1 (HIF-1) in vitro (Harms et al.,
2010) and within the adult subventricular zone (SVZ) and subgranular zone (SGZ) in
vivo (Roitbak et al., 2010). Furthermore, we have demonstrated that both embryonic and
postnatal NSPCs are primarily reliant on glycolysis and display minimal dependence on
mitochondrial oxidative phosphorylation for ATP synthesis and survival (Chapter 3).
These metabolic characteristics may be extremely important to ensure survival of NSPCs
under conditions of metabolic injury, such as severe hypoxia that can occur following
stroke or other pathological conditions. In this chapter, we describe the generation and
characterization of a unique triple transgenic mouse, nestin-CreERT2/R26R-YFP/Hif1afl/fl,
to test the hypothesis that HIF-1 represents a cell-intrinsic regulator of NSPC
metabolism, important for NSPC cytogenesis under normal and stroke conditions.
High glycolytic flux and low mitochondrial oxygen consumption under non-hypoxic
conditions is known as the Warburg effect and is driven by constitutive HIF-1
stabilization in several cancer cell types. To determine whether aerobic glycolysis in
NSPCs is also dependent on constitutive HIF-1 expression, it is necessary to utilize
methods that allow for NSPC-specific gene deletion of Hif1a. Previous studies utilizing
lentivector shRNAi resulted in a partial knockdown of HIF-1 by approximately 70%
that was not sustained over multiple passages (Roitbak et al., 2008) (and unpublished
observations). Therefore, we have utilized a Cre/LoxP approach to achieve complete
Hif1a gene deletion from NSPCs in culture and to generate mice for conditional and
inducible ablation of HIF-1 protein expression selectively from NSPCs in vivo.
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For these studies, we have crossed nestin-CreERT2/R26R-YFP mice (generated by A.
Eisch, UTSW) (Lagace et al., 2007) to mice that harbor bi-allelic floxed exon 2 of the
Hif1a gene sequence (generated by Randall Johnson, UCSD) (Ryan et al., 2000). This
approach is depicted in Figure 4.1.

The Hif1afl/fl mutant mice have been well-

characterized and utilized to generate many conditional and/or inducible transgenic mice
to study cell-type specific knockout of the Hif1a gene. Specific examples of Cre drivers
that have been used include phosphoenolpyruvate carboxykinase (PEPCK) (Higgins et
al., 2007), synapsin I (Rempe et al., 2006), nestin (Milosevic et al., 2007), and
calcium/calmodulin-dependent kinase II promoter (Sheldon et al., 2009).

Also, the

Hif1afl/fl mouse has been used to study the role of neuronal/glial HIF-1 on ischemic
tolerance in adult brain (Vangeison et al., 2008). Similarly, the nestin-CreERT2/R26RYFP mice have been crossed with loxP transgenics to study cell-intrinsic signaling
molecules that regulate neurogenesis in vivo.

For example, Gao and colleagues

demonstrated the role of NeuroD1 for survival and maturation of newborn granule cells
(Gao et al., 2009); and Lagace and colleagues utilized this line to show cyclin dependent
kinase 5 (Cdk5) as a critical neural stem cell intrinsic regulator of adult hippocampal
neurogenesis (Lagace et al., 2008).
In the present study, we established a nestin-CreERT2/R26R-YFP/Hif1afl/fl triple
transgenic mouse, and charactered Cre-mediated recombination in vitro and in vivo. Our
findings indicate that Hif1a gene deletion impairs the ability of NSPCs to survive
hypoxia, but surprisingly loss of Hif1a expression does not result in a shift in metabolic
phenotype under aerobic conditions.
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4.3 Materials and Methods
4.3.1 Generation of nestin-CreERT2/R26R-YFP/Hif1afl/fl triple transgenic mice
This study was approved by the University of New Mexico Animal Care and Use
Committee and conformed to the NIH Guidelines for use of animals in research. NestinCreERT2/R26R-YFP mice were obtained from the laboratory of Amelia Eisch at the
University of Texas Southwestern Medical Center (Lagace et al., 2007). Hif1a floxed
mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA), which were
originally generated and described by Randall Johnson’s group at the University of
California, San Diego (Ryan et al., 2000). Both the nestin-CreERT2/R26R-YFP mouse
and the Hif1a floxed mouse (Hif1afl/fl) had been crossed to the C57BL/6J background.
To generate a tamoxifen-inducible nestin-CreERT2/R26R-YFP/Hif1afl/fl mouse, the
nestin-CreERT2/R26R-YFP mouse was crossed to the Hif1a floxed mouse (Hif1afl/fl).
The first cross of these two lines generated an F1 population that was heterozygous at all
three alleles (Cre+/- YFP+/- HIFwt/fl).

Crosses made from the F1 population yielded

progeny predicted by Mendelian genetics, such that each allele segregated in a 1:2:1
fashion. Further crosses were performed by selecting for nestin-CreERT2 positive, R26RYFP homozygous, and Hif1afl/fl mice. To confirm the genotype of each mouse, DNA
from the tissue was isolated and amplified with polymerase chain reaction (PCR) using
the following primers: Cre forward 5'– ATT TGC CTG CAT TAC CGG TC -3', Cre
reverse 5'- ATC AAC GTT TTC TTT TCG G -3' (Indra et al., 1999); YFP primer 1: 5’AAA GTC GCT CTG AGT TGT TAT -3’, YFP primer 2: 5’- GCG AAG AGT TTG
TCC TCA ACC -3’, YFP primer 3: 5’- GGA GCG GGA GAA ATG GAT ATG -3’
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(Soriano, 1999); HIF forward HF26: 5’- TGATGTGGGTGCTGGTGTC -3’ and HIF
reverse HF27: 5’- TTGTGTTGGGGCAGTACTG -3’ (Schipani et al., 2001).

4.3.2 Cre-mediated recombination
NSPCs were isolated from embryonic day 14 telencephalon or post-natal day 28 SVZ
from

wild-type,

Hif1afl/fl,

nestin-CreERT2/R26R-YFP

bitransgenic,

or

nestin-

CreERT2/R26R-YFP/Hif1afl/fl triple transgenic mice by methods described previously
(Harms et al., 2010) (Chapters 2 and 3). The efficiency of Cre-mediated recombination
was tested using a) direct exposure to the tamoxifen metabolite 4-hydroxy-tamoxifen (4OH-TM) in culture, b) exposure to Ad-CMV-Cre in culture, and c) in vivo administration
of tamoxifen prior to NSPC isolation.
4.3.2.1 4-hydroxy-tamoxifen in culture
The efficacy of 4-hydroxy-tamoxifen (4-OH-TM) to induce Cre-mediated recombination
was initially tested in NSPCs isolated from nestin-CreERT2/R26R-YFP bitransgenic
mice. NSPCs were isolated from embryonic nestin-CreERT2/R26R-YFP mice as
previously described and exposed to increasing concentrations of 4-OH-TM (0.1-100
M; Sigma) for 24 h. 4-OH-TM binds to the mutated estrogen receptor (ERT2). Cremediated recombination was visualized by YFP expression in nestin-CreERT2/R26R-YFP
(see immunocytochemical procedures below).
4.3.2.2 Ad-CMV-Cre in culture
As an alternative approach to 4-OH-TM exposure, we tested the recombination efficacy
following incubation of NSPCs with adenovirus that confers Cre recombinase expression
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under the CMV constitutive transcriptional promoter. Embryonic NSPCs were isolated
from wild-type, Hif1afl/fl, or nestin-CreERT2/R26R-YFP mice and passaged twice.
Following the second passage NSPCs were plated on poly-L-lysine coated 6-well plates
(BD Biosciences) at a density of 2.6 x 104 cells/cm2 and allowed to adhere to the plate
overnight. Based on previous observations, NSPCs multiply by a factor of 2 over 24 h.
Twenty-four hours after plating, we assumed a cell density of 5.2x104 cells/cm2 and
infected cells with 0.0005x1010–0.01x1010 plaque formation units (PFU) of Ad-CMV-Cre
(Vector Biolabs, Philadelphia, PA, USA), yielding a concentration of 10-200 MOI
(multiplicity of infection). NSPCs were incubated in Ad-CMV-Cre for 48 h, then washed
and incubated in fresh media for an additional 24 h. NSPCs were then passaged twice
more before used in experiments.
4.3.2.3 In vivo tamoxifen administration
To induce Cre-mediated recombination in embryonic NSPCs, tamoxifen induction of Cre
recombinase was achieved by interperitoneal (i.p.) injection of timed pregnant females at
gestational day 10.5 (E10.5) with tamoxifen (75 mg/kg; Sigma, St. Louis, MO) dissolved
in 10% ethanol/90% sunflower oil. Two injections of tamoxifen 6 hours apart were
administered, as described (Battiste et al., 2007). On gestational day 14.5 (E14.5), the
pregnant female mice were sacrificed by isoflurane overdose and the embryos were
removed by cesarean section. To induce Cre-recombination in post-natal NSPCs, postnatal day 28 male mice were injected with tamoxifen (180 mg/kg per day) i.p. for 5
consecutive days (Lagace et al., 2007), and sacrificed 5 days after the last injection with
isoflurane overdose. NSPC cultures were set-up as described (Harms et al., 2010)
(Chapters 2 and 3). To isolate the YFP-positive population, unlabeled NSPCs were
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sorted using flow cytometry (ex/em 488 nm/530 nm; Beckman Coulter Legacy MoFlo,
Brea, CA, USA). For cell sorting, the use of an antibody was not required. YFP-positive
NSPCs were expanded in culture prior to use in experiments.

4.3.3 PCR analysis of Hif1a gene deletion from isolated NSPCs
To confirm deletion of exon 2 of the Hif1a gene either following Ad-CMV-Cre treatment
or cell sorting, DNA was isolated and efficiency of cre-recombination was detected with
PCR using forward primer 5’- TGT TAA ATA AAA GCT TGG AC -3’ and reverse
primer 5’- GCA GTT AAG AGC ACT AGT TG -3’ (Milosevic et al., 2007). Successful
DNA recombination yields Hif1a gene-deleted NSPCs (Hif1aΔ/Δ), as indicated by the loss
of the 1200 bp band amplification product and appearance of a 250 bp band.

4.3.4 Oxygen deprivation, MTT viability, and treatment with mitochondrial and
metabolic inhibitors were all performed as described previously (Chapters 2 and 3)

4.3.5 Immunocytochemistry
Cultured cells were fixed on coverslips with 4% paraformaldehyde and incubated in
monoclonal mouse anti-nestin (1:200; Chemicon, Temecula, CA, USA) and rabbit
polyclonal anti-green fluorescent protein (GFP; 1:200; Invitrogen). Immunofluorescence
was visualized using FITC- or Cy3-conjugated secondary antibodies (1:250; Jackson
ImmunoResearch Laboratories). DAPI nuclear stain was used to identify cell bodies of
cultured cells (Invitrogen). Immunofluorescence was analyzed using high-resolution
confocal microscopy (Zeiss LSM510, Thornwood, NY, USA) or conventional
fluorescence microscopy.
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4.3.6 Statistical Analyses
Data are expressed as means + S.E.M. Significant differences between means were
determined by student’s t-test, one-way analysis of variance (ANOVA) with Tukey
multiple comparisons post hoc analysis, or two-way ANOVA using Bonferroni
comparisons post hoc analysis using Prism software (Graphpad Software, San Diego,
CA, USA). P values < 0.05 are considered statistically significant.

4.4 Results
4.4.1 4-hydroxy-tamoxifen treatment of NSPCs results in high toxicity and low
recombination efficiency in culture
The nestin-CreERT2 gene drives expression of Cre recombinase fused to an estrogen
receptor containing a mutated ligand-binding domain (ERT2) that preferentially binds the
tamoxifen metabolite 4-hydroxy-tamoxifen (4-OH-TM) in nestin-positive cells (Lagace
et al., 2007). In our cultures, binding of 4-OH-TM to ERT2 induces receptor dimerization
and translocation of Cre recombinase to the nucleus, permitting Cre-mediated excision of
the STOP codon and subsequent expression of YFP.

Hayashi and McMahon

demonstrated that addition of 1 M 4-OH-TM to fibroblast cultures causes Cre-mediated
recombination to occur in vitro (Hayashi and McMahon, 2002).
To determine the efficacy and potential toxicity of 4-OH-TM, we treated embryonic
nestin-CreERT2/R26R-YFP NSPCs to increasing concentrations of 4-OH-TM (0.1-100
M) for 24 h (Figure 4.2 A). Whereas doses of 1-2 M did not appear to have cytotoxic
effects of NSPCs, we found that 10M and 100 M doses significantly decreased the

94

number of viable cells in culture by 46 and 98 percent, respectively (Figure 4.2 A). That
10 M 4-OH-TM is toxic to other cell types has been previously reported (Coezy et al.,
1982). However, YFP expression was not optimal at non-toxic doses of 4-OH-TM
(Figure 4.2 C). These results indicate low efficacy and high toxicity of 4-OH-TM to
NSPCs in culture.

4.4.2 Ad-CMV-Cre stimulates highly efficient recombination in vitro with low toxicity
We tested the use of adenovirus that utilizes a strong constitutive cytomegalovirus
(CMV) promoter to drive Cre recombinase expression (Ad-CMV-Cre) in transduced
NSPCs. Initial studies were performed to determine the dose and timecourse for use of
Ad-CMV-Cre on NSPCs cultured from bitransgenic embryonic nestin-CreERT2/R26RYFP mice. Cultures were incubated with Ad-CMV-Cre up to 48 h at multiplicities of
infection (MOI) of 10-200, based on a previous report performed in mouse primary
osteoblasts (Fulzele et al., 2007). Cell viability, as measured using MTT reduction, was
not reduced by viral infections of 10-100 MOI Ad-CMV-Cre after 48 h incubation.
However, at 200 MOI the adenoviral vector was cytotoxic to NSPCs (Figure 4.3 A).
Confocal images of fixed cultures stained with an antibody against green fluorescent
protein (GFP) revealed maximal YFP reporter gene expression with incubation of AdCMV-Cre at a dose of 50 MOI for 48 h (Figure 4.3 B), indicating maximal Cre
recombinase-induced recombination at this dose.
Prior to completion of the triple-transgenic nestin-CreERT2/R26R-YFP/Hif1afl/fl mouse,
preliminary studies to delete Hif1a from NSPCs in culture were performed on cells
obtained from Hif1afl/fl mice using Ad-CMV-Cre. To delete Hif1a from NSPCs in
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culture, Ad-CMV-Cre was added at a dose of 50 MOI for 48 h to NSPCs cultured from
Hif1afl/fl mice. As reported in Chapter 2 of this dissertation, PCR of genomic DNA
isolated from these cells failed to amplify exon 2 sequences in the Hif1a gene, indicating
that recombination between the loxP sites was effective (Figure 2.5 A). Transcriptional
activity of HIF-1 protein was ablated as determined by an HRE Binding Activity assay
(Figure 2.5 B). Based on these data, the estimated efficiency of recombination induced
by 50 MOI Ad-CMV-Cre is 100%. The results suggest high recombination efficiency at
non-toxic doses of Ad-CMV-Cre.

4.4.3 In vivo deletion of Hif1a using nestin-CreERT2/R26R-YFP/Hif1afl/fl
To create a mouse where Hif1a could be specifically deleted from nestin-positive NSPCs
in vivo, we crossed the nestin-CreERT2/R26R-YFP mouse to the Hif1afl/fl mouse as
described under the Methods section. To track the segregation of the alleles for the three
genes, nestin-CreERT2, R26R-YFP, and Hif1afl/fl, PCR was performed with genomic
DNA from tissue of each animal. For the Hif1a gene, the PCR product from the wildtype gene appeared around 300 bp whereas the product from the floxed allele appeared at
around 350 bp, due to inclusion of one loxP site (Figure 4.4 A). The PCR of genomic
DNA in Figure 4.4 B illustrates one animal that is homozygous for the R26R-YFP
transgene (YFP+/+), positive for nestin-CreERT2 (Cre+), and homozygous for the mutant
floxed Hif1a gene (HIFfl/fl), demonstrating our ability to create a nestin-CreERT2/R26RYFP/Hif1afl/fl triple-transgenic mouse (Figure 4.4 B).
Recombination of the DNA between two loxP sites is required for the excision of the
intervening sequence. To stimulate Cre expression, mice were injected with tamoxifen,
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the metabolite of which binds to the mutated estrogen receptor (ERT2), allowing CreERT2
to translocate to the nucleus in nestin-positive cells. In these triple-transgenic mice, cremediated excision permits YFP expression and simultaneous deletion of exon 2 of the
Hif1a gene to disrupt the generation of a functional HIF-1 protein. To ensure Hif1a
deletion, Cre-mediated excision at both loci was determined by expression of YFP.
NSPCs were sorted following in vitro expansion after two passages using a flow
cytometer capable of single cell deposition. Cellular expression of YFP was excited by
the laser (ex 488 nm) without the need to label with an antibody, and YFP+ cells were
found to be 10-25% of the total cell population (Figure 4.4 C and D). Only the YFP+
cells were collected and expanded for experiments. PCR analysis of genomic DNA
isolated from YFP+ NSPCs in culture confirmed that exon 2 of the Hif1a gene was
successfully deleted from all YFP+ cells (Figure 4.4 E). Data shown in figures 4.4 C-E
were generated from postnatal NSPCs; however, similar data were obtained from
embryonic NSPCs (data not shown).

4.4.4 Impact of Hif1a gene deletion on NSPC metabolic phenotype
4.4.4.1 Hif1a deletion impairs NSPC survival under hypoxia
We reported previously that NSPCs survive 24 h anoxia, and that they express basal
levels of HIF-1 protein which is upregulated with anoxia (Harms et al., 2010) (Chapter
2). To determine whether HIF-1 expression is required for NSPCs to remain viable
during anoxia, nestin-CreERT2/R26R-YFP/Hif1awt/wt vs. nestin-CreERT2/R26RYFP/Hif1aNSPCs were exposed to 24 h anoxia. The number of surviving NSPCs was
reduced by over 45% with Hif1a gene deletion (Figure 4.5 A). These data confirmed our
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preliminary findings using Ad-CMV-Cre to delete Hif1a in vitro (Figure 4.5 B). These
data suggests that NSPCs require HIF-1 expression to survive 24 h anoxia.
4.4.4.2 Hif1a NSPCs remain insensitive to mitochondrial toxins
HIF-1 has been shown in cancer cells to control expression of genes involved in cellular
metabolism (Semenza, 2010b), including upregulation of glucose transporters and
glycolytic enzymes, including lactate dehydrogenase (LDH). HIF-1 also upregulates
the enzyme pyruvate dehydrogenase kinase (PDK), which phosphorylates and deactivates
pyruvate dehydrogenase (PDH), preventing the conversion of pyruvate into acetyl-CoA
for use in the tricarboxylic acid (TCA) cycle (Kim et al., 2006; Papandreou et al., 2006).
Electrons generated by the TCA cycle are used in the electron transport chain to carry out
oxidative phosphorylation, where the reduction of oxygen is coupled to the
phosphorylation of ADP to generate ATP. Cytochrome c oxidase is the complex of the
electron transport chain that uses oxygen as a final electron acceptor, which can be
chemically inhibited by cyanide. We showed previously that while cyanide is cytotoxic
to neurons, a cell that relies on oxidative metabolism, it is not cytotoxic to NSPCs
(Chapter 3). Since deletion of Hif1a from NSPCs rendered these cells susceptible to
oxygen deprivation (Figure 4.5), we asked whether Hif1a-deleted NSPCs would also be
susceptible to cyanide treatment, as cyanide and oxygen would be expected to act on the
same electron transport complex.
Experiments employing the tamoxifen-inducible system to induce recombination in vivo
using NSPCs isolated from nestin-CreERT2/R26R-YFP/Hif1a vs. nestinCreERT2/R26R-YFP/Hif1awt/wt revealed that Hif1adeletion does not render NSPCs
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susceptible to cyanide treatment (1 mM; Figure 4.6 A), a similar finding as data
generated from Ad-CMV-Cre-induced deletion of Hif1a (Figure 4.6 G). Furthermore,
Hif1a deletion in NSPCs did not change their sensitivity to the ATP synthase inhibitor
oligomycin (1 M; Figure 4.6 B) nor to the complex I inhibitor rotenone (1 M; Figure
4.6 C). Dose-response curves for cyanide, oligomycin, and rotenone appear in the
Appendix (Figure B1). These data suggest that HIF-1 does not regulate NSPC use of
mitochondrial respiration.
4.4.4.3 Hif1aNSPCs remain glycolytic
To determine whether HIF-1 regulates the glycolytic phenotype of NSPCs described
previously (Chapter 3), glycolysis was blocked using the hexokinase inhibitor 2-deoxyD-glucose (2-DG; 10 mM) and pyruvate (10 mM) was added as an alternative substrate
to glucose. Interestingly, tamoxifen-induced Hif1a deletion did not increase NSPC
ability to utilize pyruvate (Figure 4.6 D), a finding similar to data generated from Hif1afl/fl
NSPCs treated with Ad-CMV-Cre (Figure 4.6 H). In addition, NSPC utilization of
pyruvate and glutamine in the presence of the glycolytic inhibitor galactose was not
upregulated with Hif1a deletion (Figure 4.6 E). Whereas NSPCs display a glycolytic
metabolic phenotype (Chapter 3), these data indicate that HIF-1does not regulate this
phenotype.
Treatment of nestin-CreERT2/R26R-YFP/Hif1aNSPCs with the pentose phosphate
shunt inhibitor 6-aminonicotinamide (6-AN; 500 M) resulted a small but significant
increase in the number of viable cells compared to nestin-CreERT2/R26R-
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YFP/Hif1awt/wtNSPCs (Figure 4.6 F). These data suggest that HIF-1 may play a role in
NSPC reliance on the pentose phosphate shunt.

4.5 Discussion
The nestin-CreERT2/R26R-YFP/Hif1afl/fl mouse allows for conditional induction of Cre
recombinase in nestin-positive cells in vivo, induced with tamoxfen injection at a chosen
point in time in development or adulthood. This model circumvents the problems that
arise from addition of inducers of Cre recombinase into culture media. Whereas others
have found that addition of 4-OH-TM to culture media induces cre-recombination in
fibroblasts cultured from CreERT2 mice (Hayashi and McMahon, 2002), we found that
non-toxic concentrations of 4-OH-TM did not provide sufficient recombination in our
cultures. The reason for this discrepancy may be due to reporter expression differences
(-galactosidase activity vs. YFP expression).
Ad-CMV-Cre-mediated recombination led to greater expression of YFP compared to 4OH-TM-induced Cre expression. The increased efficiency of recombination with AdCMV-Cre is likely due to the higher levels of Cre recombinase expression that is driven
by the cytomegalovirus promoter, and the independence from tamoxifen-mediated
nuclear translocation. Although treatment of NSPCs with Ad-CMV-Cre did not appear
to impact NSPC viability, we observed an inability of NSPCs to survive differentiation
following growth factor withdrawal in cultures treated with adenovirus (data not shown).
Thus, Ad-CMV-Cre treatment provides a useful tool for studying the in vitro effects of
Hif1a deletion on NSPC metabolism, but may not be appropriate for studies focused on
lineage fate in vitro or in vivo.
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Use of tamoxifen to stimulate recombination in vivo prior to isolation of NSPCs allows
for tamoxifen clearance prior to harvesting of the recombined NSPC cell population.
This ensures that any interaction tamoxifen would have with endogenous estrogen
receptors are avoided during experimentation. In addition, Cre-mediated recombination
in the nestin-CreERT2/R26R-YFP/Hif1afl/fl mouse turns on the genetic reporter gene
(YFP), which provides an indelible label marking recombined cells and all progeny.
Intraperitoneal (i.p) administration of tamoxifen to nestin-CreERT2/R26R-YFP/Hif1awt/wt
and nestin-CreERT2/R26R-YFP/Hif1afl/fl mice yielded a recombined population of YFPpositive cells that reflected only 10-25% of the total NSPCs population expanded in
culture from both embryonic and post-natal mice. We anticipated a higher recombination
efficiency since our NSPC cultures are uniformily nestin-positive (Chapter 2, Figure 2.2).
This correlates with our observation in vivo that only 20% of doublecortin-positive
migrating neuroblasts expressed YFP six weeks following transient middle cerebral
artery occlusion (MCAO) in nestin-CreERT2/R26R-YFP mice (Li et al., 2010)
(Appendix). The in vitro capability to sort out the YFP-positive NSPCs ensures a
relatively pure population of recombined cells for ex vivo study. Following cell sorting,
YFP-positive NSPCs proliferate in culture, survive multiple passages, maintain YFP
expression, and, in the case of nestin-CreERT2/R26R-YFP/Hif1a cells, maintain
deletion of exon 2 of the Hif1a gene. Therefore, suboptimal labeling efficiency using
tamoxifen injections does not hinder our ability to use these cells for experiments in cell
culture.
We have also begun to characterize the in vivo behavior of Hif1a-deleted NSPCs
following tamoxifen administration to adult nestin-CreERT2/R26R-YFP/Hif1afl/fl mice.
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Preliminary data suggest that Hif1a gene deletion results in NSPC depletion from SVZ
and SGZ and a reduced cytogenic response to stroke (Appendix C).
Prior to the creation of this model, it was not possible to delete Hif1a from nestin-positive
NSPCs in vivo. Systemic deletion of Hif1a results in embryonic lethality by embryonic
day 11 due to underdevelopment of the vasculature and cardiac malformation (Iyer et al.,
1998; Ryan et al., 1998; Kotch et al., 1999). Deletion of Hif1a from nestin-positive cells
driven by Cre recombinase activity throughout embryonic development leads to
hydrocephalus, neuronal loss, decreased proliferation, and impaired spatial memory
(Tomita et al., 2003, Milosevic, 2007 #116). Administration of tamoxifen to activate Cre
recombinase in adult mice allows the animal to develop normally prior to Cre-mediated
excision of Hif1a, Thus, the results of our studies are not confounded by impairments in
brain development.
In addition to deletion of Hif1a, tamoxifen-induced Cre-recombination turns on the
expression of YFP in nestin-positive cells. This provides us with a tool to map the fate of
recombined NSPCs (see the appended manuscript (Li et al., 2010)). This method has
advantages over the use of bromodeoxyuridine (BrdU), a thymidine analog that
incorporates into dividing cells during S phase, which is diluted as the cell divides and
can also label damaged cells undergoing DNA repair (Gould and Gross, 2002; Rakic,
2002; Taupin, 2007). In the genetic model, the “unstopped” YFP gene is transmitted
genetically and YFP is maintained in all progeny originally induced to express Cre
recombinase.
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The ability of HIF-1 to protect NSPCs from anoxia-induced cell death was not
surprising given its ability to regulate genes involved in the survival of hypoxic cancer
cells (Semenza, 2003). In most cell types, HIF-1 protein is degraded when oxygen is
present. However, under hypoxia, HIF-1 protein is stabilized and able to enter the
nucleus to act as a transcription factor (Semenza, 2003).

In cancer cells, HIF-1

transcriptional regulation of glycolytic enzymes shifts cellular metabolism away from the
mitochondria, even when oxygen is abundant, to exclusively glycolytic (Seagroves et al.,
2001), where cells produce all required ATP via glycolysis (Warburg effect). Given our
observation that NSPCs also utilize glycolysis without mitochondrial metabolism, and
that HIF-1 protein is stabilized in normoxic NSPCs, we hypothesized that HIF-1
regulates the metabolic phenotype of NSPCs. However, our data suggest unexpectedly
that HIF-1 does not regulate this phenotype as NSPCs remain glycolytic in the absence
of HIF-1. How HIF-1 regulates the ability of NSPCs to survive anoxia remains to be
determined.
Of interest is that HIF-1 deletion decreases NSPC susceptibility to the pentose
phosphate pathway inhibitor 6-AN. The pentose phosphate pathway is required for
nicotinamide adenine dinucleotide phosphate (NADPH) production as well as nucleotide
synthesis. HIF-1 has been shown previously to enhance the rate of pentose phosphate
pathway activity (Soucek et al., 2003). Production of NADPH has been shown to combat
the production of reactive oxygen species, for NADPH serves as a cofactor for
antioxidant enzymes and acts to maintain high levels of reduced glutathione, an
antioxidant. In conjunction with our findings that NSPCs rely more heavily on the
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pentose phosphate pathway than neurons (Chapter 3), constitutive expression of HIF-1
may act to regulate the reliance of NSPCs on this pathway.
Adult NSPCs reside within complex microenvironmental niches specialized to support
NSPC self-renewal and to regulate the production of newborn neurons and glia within the
adult brain.

The ability to parse microenvironmental NSPC-extrinsic factors (e.g.

vasculature,

secreted

factors,

extracellular

matrix,

cell-cell

interactions,

neurotransmitters) vs. NSPC-intrinsic molecular mediators (e.g. cyclins, intracellular
signaling cascades) of adult neurogenesis has been greatly facilitated by the use of
inducible genetic approaches in which gene expression can be manipulated specifically in
NSPCs within the context of the adult brain. The inducible model can be used to study
the importance of NSPC-specific HIF-1 both in vitro and in vivo, and its role in
proliferation, migration, and differentiation without affecting the development of the
animal. This model will serve as a tool to better understand the role of HIF-1 in NSPCs
under non-pathological conditions as well as recovery following stroke.

4.6 Figure Legends
Figure 4.1: Diagram of genetic manipulations to create nestin-specific Hif1a knockout mice. Recombination in nestin-CreERT2/R26R-YFP/Hif1afl/fl triple transgenic mice
is induced with tamoxifen to drive expression of YFP and delete exon 2 of the Hif1a
gene.
Figure 4.2: Cre-mediated recombination using 4-OH-TM. (A) MTT colorimetric
viability assays measuring the viability of embryonic NSPCs from nestin-CreERT2/R26RYFP mice treated with 4-OH-TM for 24 h compared to untreated controls. (B,C) NSPCs
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grown from embryonic nestin-CreERT2/R26R-YFP mice were untreated (B) or treated
with 2 M 4-OH-TM (C). Fixed cells were labeled with antibodies to detect yellow
fluorescent protein (GFP; green) and nestin (red). Images taken at 40X. ***p<0.001. n=3
per treatment group.
Figure 4.3: Cre-mediated recombination using Ad-CMV-Cre. (A) MTT colorimetric
viability assay measuring the viability of embryonic NSPCs from nestin-CreERT2/R26RYFP mice in the presence of increasing concentrations of Ad-CMV-Cre (10-200 MOI)
for 48 h compared to untreated controls. (B) Immunocytochemistry for nestin (red) and
YFP (green) of fixed nestin-CreERT2/R26R-YFP embryonic NSPCs following 48 h
incubation in 50 MOI Ad-CMV-Cre. Scale bar = 20 m. *p<0.05. n=3 per treatment
group.
Figure 4.4: Tamoxifen-inducible Cre-mediated recombination. (A) PCR products
generated using primers to detect Hif1aalleles, both wild-type (HIFwt/wt) and floxed
(HIFfl/fl). Genomic DNA was isolated from tissue. (B) PCR products generated using
primers to detect the presence of R26R-YFP (YFP+/+), nestin-CreERT2 (Cre+), and
Hif1afl/fl (HIFfl/fl) alleles. The gel shown depicts one mouse that is homozygous at all
three genes. Genomic DNA was isolated from tissue. (C) Cell sorting using flow
cytometry of nestin-CreERT2/R26R-YFP/Hif1awt/wt post-natal NSPCs using a 488 nm
laser. The YFP+ (R2 and R3) population is approximately 25% of the total number of
cells. (D) Cell sorting using flow cytometry of nestin-CreERT2/R26R-YFP/Hif1a postnatal NSPCs using a 488 nm laser. The YFP+ (R2 and R3) population is approximately
10% of the total number of cells. (E) PCR products produced from the amplification of
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genomic DNA isolated from post-natal NSPCs grown in culture from both cells that were
unsorted and those that were sorted using flow cytometry for expression of YFP.
Deletion of exon 2 from Hif1a is indicated by the loss of the 1200 bp band amplification
product and appearance of a 250 bp band (HIF).
Figure 4.5: NSPC viability in the presence of 24 h anoxia. (A,B) MTT colorimetric
viability assay of embryonic NSPCs exposed to 24 h anoxia. (A) Cre recombinase was
induced

with

injection

of

tamoxifen

into

nestin-CreERT2/R26R-YFP/Hif1awt/wt

(Cre/YFP/HIFwt/wt) and nestin-CreERT2/R26R-YFP/Hif1a (Cre/YFP/HIF) mice.
Experiments were performed on YFP+ NSPCs. (B) Cre recombinase was induced in
Hif1afl/fl NSPCs with the addition of Ad-CMV-Cre (HIF). Wild-type cultures also
received Ad-CMV-Cre (HIFwt/wt). **p<0.01. n=4 per treatment group.
Figure 4.6: Effect of Hif1agene deletion on NSPC metabolic phenotype. MTT
colorimetric viability assays of embryonic NSPC cultures. (A-F) NSPCs cultured from
embryonic

nestin-CreERT2/R26R-YFP/Hif1awt/wt

(Cre/YFP/HIFwt/wt)

and

nestin-

CreERT2/R26R-YFP/Hif1a (Cre/YFP/HIF) mice where Cre-mediated recombination
was induced in vivo using tamoxifen. Cultures were treated with the following inhibitors
for 24 hr: (A) cyanide (1 mM), (B) oligomycin (1 M), (C) rotenone (1 M), (D) 2deoxy-D-glucose (2-DG; 10 mM) plus pyruvate (10 mM), (E) galactose (25 mM) plus
pyruvate (1 mM), and (F) 6-aminonicotinamide (6-AN; 500 M). (G-H) NSPCs cultured
from wild-type (HIFwt/wt) and Hif1a (HIF) embryonic NSPCs where crerecombination was induced by Ad-CMV-Cre. NSPCs were treated with the following
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inhibitors for 24 h: (G) cyanide (1 mM) and (H) 2-deoxy-D-glucose (2-DG; 10 mM) plus
pyruvate (0.1-100 mM). **p<0.01. n=3-4 per treatment group.
Figure B1: Dose-response to mitochondrial inhibitors. (A-C) Nestin-CreERT2/R26RYFP/Hif1awt/wt

(Cre/YFP/HIFwt/wt)

and

nestin-CreERT2/R26R-YFP/Hif1a

(Cre/YFP/HIF) cultures were exposed to the following inhibitors for 24 h at normoxia:
(A) cyanide (0.1-1 mM), (B) oligomycin (0.1-10 M), and (C) rotenone (0.1-100 M).
(D) Dose-response of wild-type and Hif1a embryonic NSPCs treated with Ad-CMVCre to cyanide (0.1-2 mM) for 24 h at normoxia.
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Figure 4.1: Diagram of genetic manipulations to create nestin-specific Hif1a knock-out mice
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Figure 4.2: Cre-mediated recombination using 4-OH-TM
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Figure 4.3: Cre-mediated recombination using Ad-CMV-Cre

110

Figure 4.4: Tamoxifen-inducible Cre-mediated recombination
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Figure 4.5: NSPC viability in the presence of 24 h anoxia
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Figure 4.6: Effect of Hif1agene deletion on NSPC metabolic phenotype
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5. Discussion
5.1 Summary
These studies have provided increased understanding of the role of HIF-1 in the
regulation of NSPC function under both non-pathological and ex vivo ischemic
conditions (Figure 5.1). We have demonstrated that NSPCs constitutively stabilize HIF1 protein which underlies their resistance to brief periods of OGD and prolonged
periods of hypoxia. In addition, we have demonstrated that HIF-1-regulated VEGF
signaling protects neurons against ischemic death, supporting a beneficial role for NSPCs
following stroke. We have also characterized the metabolic phenotype of NSPCs as
primarily glycolytic with relatively low dependence on oxidative phosphorylation for
survival. We have demonstrated, nevertheless, that HIF-1 is not essential to maintain
glycolytic dependence. Finally, we have established and characterized a novel nestinCreERT2/R26R-YFP/Hif1afl/fl triple transgenic mouse for conditional and inducible Hif1a
gene deletion in nestin-positive NSPCs in vivo that can be used to study NSPC properties
both in vivo and ex vivo. Initial characterization of these mice indicate that Hif1a gene
deletion in adult NSPCs in vivo results in the depletion of the NSPC pool within the SVZ
and SGZ and attenuation of the SVZ cytogenic response to stroke. These studies support
a role for HIF-1 as an intrinsic regulator of NSPC survival and function in response to
cerebral ischemia and provide increased understanding of NSPC bioenergetics and
metabolism.
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Neurotrophic
Survival following hypoxia

VEGF

Support

HIF-1

Maintenance of Glycolytic Phenotype

Maintenance of the Stem Cell Pool
SVZ Cytogenic Response to Stroke

Figure 5.1: HIF-1 regulation of NSPC phenotype. This dissertation describes a role
for NSPC-specific HIF-1, including the regulation of survival during hypoxia, VEGF
production and subsequent neuroprotection. Preliminary data (Appendix) suggests HIF1 maintains the neural stem cell pool following stroke in vivo. We found that HIF-1
does not regulate the metabolic phenotype of NSPCs in culture.

5.2 NSPC-mediated neuroprotection
We demonstrated that NSPCs protect cortical neurons against ischemic cell death via
HIF-1-regulated VEGF signaling in vitro using oxygen-glucose deprivation (OGD) as a
model. In vitro modeling allowed us to compare the specific effects of hypoglycemia,
hypoxia, and metabolic inhibition between neurons and NSPCs, and to thereby determine
the cell-specific impact on viability and metabolic phenotype. These studies provide
support to the hypothesis that the SVZ cytogenic response to stroke may be beneficial to
the ischemic brain by protecting penumbral neurons against delayed neuronal cell death.
Future studies will be aimed at understanding the implications of our in vitro findings to
the in vivo environment of the ischemic brain.
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The SVZ NSPC cytogenic response to stroke is delayed, with proliferation peaking at 2
weeks post-MCAO (Thored et al., 2006). Therefore, NSPC-mediated neuroprotection
may occur in the immediate vicinity of the SVZ (medial striatum) during the early poststroke event, but may also be important as NSPCs undergo migration into the injured
penumbral regions. Furthermore, some evidence suggests a small population of resident
parenchymal stem cells that may not originate from the SVZ, which could provide local
neuroprotection if activated early (Shimada et al., 2010). It would be anticipated that
both HIF-1 and VEGF would be upregulated in vivo following MCAO as we have
shown in vitro following OGD and hypoxia, since the partial pressure of O2 drops to
<1.4% immediately following MCAO (Thored et al., 2007).

Whether neural

stem/progenitor cells express VEGF in vivo remains to be determined. To study the role
of NSPC-specific VEGF in vivo, we could cross the nestin-Cre-ERT2/R26R-YFP mouse
to a VEGF floxed mouse. With this model, VEGF deletion from NSPCs would be
induced with tamoxifen and the amount of ischemic damage could be measured.

5.3 NSPC bioenergetics
We demonstrated that NSPCs are primarily glycolytic and have low dependence on
oxidative phosphorylation. The ability of NSPCs to survive severe hypoxia and mount a
proliferative response to cerebral ischemia may result from their use of glycolysis under
normoxic conditions. NSPCs closely associate with the vasculature (Mirzadeh et al.,
2008; Shen et al., 2008; Tavazoie et al., 2008; Li et al., 2010), possibly due to their
reliance on glucose metabolism and requirement for a glucose source. Use of glycolysis
over mitochondrial respiration may aid in NSPC proliferation and migration capabilities,
by avoiding flux through the electron transport chain. This would limit ROS production
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that can lead to DNA damage and disruption of the maintainence of the stem cell
phenotype.
We found that HIF-1does not regulate the glycolytic phenotype of NSPCs. This was
surprising given previous reports that HIF-1 regulates the transcription of genes that
promote glycolysis (Seagroves et al., 2001). However, HIF-1 is not the only known
regulator of the glycolytic phenotype. For example, c-Myc expression enhances the
glycolytic pathway through upregulation of glycolytic enzymes including LDHA. HIF1 negatively regulates c-Myc, so deletion of Hif1a may very well increase activity of cMyc in our cultures (Gordan et al., 2007), and there is evidence that c-Myc regulates
metabolism in cerebellar granule neural progenitor development (Wey et al., 2010).
Conversely, p53 has been shown in cancer cells to suppress glycolysis and downregulate
glucose transporters (Schwartzenberg-Bar-Yoseph et al., 2004; Kondoh et al., 2005;
Matoba et al., 2006). Determining whether lack of p53 regulation in NSPCs determines
the glycolytic phenotype we observe could be resolved by overexpression of p53.
We have shown that HIF-1 target genes appear to be essential for the cytogenic
response mounted by NSPCs in the SVZ for both autocrine (NSPC survival under
hypoxia) and paracrine (neuronal survival) signaling. How HIF-1regulates the ability
of NSPCs to survive prolonged anoxia remains to be determined. Genes transcriptionally
regulated by HIF-1 include neuroprotective factors. We determined that autocrine
signaling via VEGF production is not required for NSPC survival under OGD, nor do
NSPCs produce BDNF in culture. Future studies could investigate whether cultured
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NSPCs require expression of autocrine EPO production, a likely candidate for protection
of NSPCs following anoxia.

5.4 Conditional-Inducible Hif1a knockout mice
We generated and have begun to characterize a unique triple transgenic mouse for
conditional, inducible Hif1a gene deletion. We were able to isolate NSPCs from these
mice and expanded them in culture without loss of viability. Our genomic analysis
demonstrated homozygosity for the Hif1afl/fl alleles as well as the R26R-YFP alleles, and
at least one allele for nestin-CreERT2 in the mice we used for our experiments. PCR
analysis has demonstrated gene deletion of exon 2 of Hif1a following in vivo tamoxifen
administration, but Western blot analysis is still required to verify HIF-1 protein
depletion.
Interestingly, Hif1a knockout NSPCs survive and expand normally in culture; however,
preliminary data suggest that Hif1a-gene deletion results in NSPC depletion within the
adult SVZ in vivo (Appendix). It may be that in vivo gene deletion occurs not only in
nestin-positive transient amplifying progenitor cells but also in the primitive slowly
dividing astrocytic stem cells. If the more primitive cell type is reliant on HIF-1 for
normal survival in vivo this would result in eventual depletion of all NSPCs and their
progeny. It will be important to determine whether the survival of GFAP+/nestin+
population is differentially impaired by Hif1a gene deletion in vivo. These mice also
showed a decreased cytogenic response in vivo, which may have been due to a depleted
NSPC pool and may involve limited proliferation or migration. Further studies will be
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aimed at understanding how the properties of NSPCs we discovered in culture relate to
their properties in vivo.

5.5 Critique of Research
5.5.1 In vitro modeling
Neural stem/progenitor cells exist in a niche where cell-cell interactions occur between
neurons, astrocytes, ependymal cells, and the vasculature (Mirzadeh et al., 2008; Shen et
al., 2008; Tavazoie et al., 2008). Ideally, researching NSPCs in their niche would
provide the most insight as to how NSPCs interact in their environment in vivo. Our
laboratory employs the transient middle cerebral artery occlusion (MCAO) model in mice
to understand the in vivo effects of ischemic stroke.

However, understanding cell-

specific mechanisms is best studied using in vitro techniques. In vitro modeling allowed
us to compare the specific effects of hypoglycemia, hypoxia, and metabolic inhibition
between neurons and NSPCs, and determine the cell-specific impact on viability and
metabolic phenotype. In addition, in vitro modeling helped us utilize fewer resources,
such that many experiments were performed from fewer animals.
One way we investigated cell-cell interactions in vitro is to use a coculture system, where
neurons and NSPCs were cultured together. However, in understanding the limitations of
an in vitro system, we utilized a mouse model to study the effects of cerebral ischemia on
nestin-positive stem cells and created a transgenic mouse model to determine how HIF1 regulates those effects (Chapter 4 and Appendix). The combination of in vitro with in
vivo techniques will provide a greater understanding of the role of NSPCs in brain repair
following stroke.
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5.5.2 Primary cell culture of cortical neurons and neural stem/progenitor cells
In order to study cell-specific mechanisms in vitro, neurons and NSPCs were isolated
from mouse brain. Primary cortical neurons were consistently isolated from gestational
day 15.5 embryonic mice. These cells were dissociated from the cerebral cortex after
removal of the meninges, striatum, and hippocampal ridge from the telencephalon.
Neurons were cultured in serum-free conditions to prevent the growth of astrocytes,
which are also prevalent in the cortex at this gestational age. However, approximately 12% of cells in neuronal cultures are astrocytes (Wetzel et al., 2008) and the number of
astrocytes from culture to culture could potentially vary between experiments. Because
astrocytes and neurons exhibit differential properties (e.g. cellular metabolism), the
presence of astrocytes in neuronal cultures could change the outcome of our experiments.
The age of the cultured neurons could also impact our results. Cortical neurons are
difficult to culture from adult brain, thus we utilize embryonic day 15.5 neurons.
Whether post-mitotic neurons from embryonic brain display the same properties as adult
neurons remains to be determined. One way to investigate the properties of a mature
adult neuron would be to differentiate an adult NSPC into a post-mitotic neuron.
NSPCs were either cultured from embryonic day 14.5 mouse telencephalon or postnatal
day 28 mouse SVZ. Dissection from either age results in the isolation of a variety of cell
types within these brain regions. Use of the growth factors basic fibroblast growth factor
(bFGF) and epidermal growth factor (EGF) selects for mitotically active stem and
progenitor cells.

The stem cell population is selected for using bFGF whereas the

transient amplifying progenitor population is selected for using EGF (Doetsch et al.,
1997; Riquelme et al., 2008), and serum-free conditions discourage differentiation and
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the growth of astrocytes. However, the precise ratio of stem to progenitor cells could
vary between cultures. In addition, NSPCs were used a different passage numbers for
each experiment which could also change the ratio of stem cells to progenitors. Age
appears to be a factor in NSPC cultures. We observed differences between embryonic
and postnatal NSPCs, such as the ability of postnatal NSPCs to withstand higher doses of
mitochondrial inhibitors. NSPCs from an aged brain, which may better mimic cells from
a brain that would undergo stroke, may exhibit different properties than embryonic or
postnatal NSPCs.
Cell culture in the presence of growth factors stimulates tyrosine kinase activity and
PI3K/Akt signaling that drive glycolysis (Vander Heiden et al., 2009). It could therefore
be argued that the glycolytic phenotype we observe in cultured NSPCs is an artifact of
cell culture. This could be resolved in vivo using

18

F-deoxyglucose positron emission

tomography where accumulation of this 2-DG analog in the SVZ could be compared to
cortical tissue.
Both neurons and NSPCs were cultured in media containing 25 mM glucose. However,
blood glucose levels in vivo range from 8 mM in the human (MacKay, 1932) to 10 mM in
the rat (Sun et al., 2003). High glucose levels in cultured cells contributes to the Crabtree
effect, where cells shift away from ATP production via the electron transport chain to
ATP production via glycolysis due to an excess of substrate (Frezza and Gottlieb, 2009).
Neurons require 25 mM glucose to survive in culture (Russell et al., 2002), and appeared
to maintain oxidative metabolism in our studies. However, future studies to determine
whether NPSCs display the Crabtree effect could be resolved by testing the metabolic
phenotype of NSPCs under lower concentrations of glucose.
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The ability of NSPCs to resist sudden onset hypoxia in vivo, together with the
observation that many other stem cell types have low oxygen consumption rates under
normoxic conditions, would argue against a culture artifact, but in vivo studies will be
required to confirm this.

5.5.3 Oxygen-glucose deprivation as a model of cerebral ischemia
To model cerebral ischemia in neurons and NSPCs in vitro, we utilized oxygen-glucose
deprivation (OGD). This model is a well-characterized and popular in vitro model used
to study the effects of ischemia on cultured neurons (Goldberg and Choi, 1993; MartinVillalba et al., 2001; Plesnila et al., 2001). Ischemic stroke occurs with the blockade of
blood flow to brain tissue, preventing the delivery of oxygen and glucose to the core of
the infarct by the vasculature. Neuronal cells in the ischemic penumbra surrounding the
core of the infarct die by delayed programmed cell death (apoptosis), which is
characterized by DNA fragmentation, membrane blebbing, and the formation of apoptotic
bodies which are phagocytosed by surrounding microglia.

This model mimics the

programmed cell death that neurons undergo in the penumbral region (Martin-Villalba et
al., 2001; Plesnila et al., 2001; Wetzel et al., 2008).
The OGD model was initially developed using Earle’s Balanced Salt Solution (EBSS) to
incubate the cells during the insult. EBSS is glucose- and pyruvate-free, and devoid of
amino acids. For our studies performing 2 h OGD, we utilized EBSS as this technique
has provided consistent results to model neuronal ischemia (Chapter 2). However, to
study the effects of prolonged anoxia on NSPCs, we changed our protocol to use glucoseand pyruvate-free Neurobasal media with necessary supplementation (Chapter 3 and 4).
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Our rationale for making this change was to ensure that we were studying the effects of
oxygen-deprivation on our cultures, and not amino acid, growth factor, or antioxidant
deprivation. Even still, this model does not mimic all of the events that follow ischemic
stroke, and thus only allows us to study the effects of hypoglycemia and oxygendeprivation on our chosen cell types.

5.5.4 MTT assay as a measure of cell viability
In order to measure cell viability in vitro, we utilized the MTT assay to measure viability
of both neuronal and neural stem/progenitor cells. Methylthiazolyldiphenyl-tetrazolium
bromide (MTT) is a tetrazolium salt that is reduced to a water-insoluble purple formazan
by mitochondrial dehydrogenase enzymes. The amount of reduction that occurs can be
measured by detection of a color change using a spectrophotometer (see Materials and
Methods sections in Chapters 2, 3, and 4). Active dehydrogenases of living cells cause
this conversion whereas dead cells cannot make this change. Therefore, the measurement
of MTT reduction is widely used as a cell viability assay. The caveats to using the MTT
assay include the inability to distinguish survival versus proliferation. In addition, MTT
may be reduced by NADH and NADPH directly (Berridge et al., 2005), which are
coenzymes that exist outside of mitochondrial metabolism. Verification of cell viability
can be resolved by using other cell survival assays in parallel with MTT, such as calcein
AM, or by immunocytochemistry analysis of healthy appearing nuclei using a nuclear
stain such as DAPI. Distinguishing cell viability from survival can also be determined
through the use of immunocytochemistry by staining for the cell cycle marker Ki67 or for
the thymadine analog bromodeoxyuridine (BrdU).
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5.6 Unresolved issues for the study
Whereas this dissertation describes a role for HIF-1 in NSPCs under conditions of
hypoxia, questions still remain. Unanswered questions include those regarding NSPC
age and their phenotypes in vitro vs. in vivo. For example, embryonic NSPCs appear to
survive mitochondrial inhibition but their oxygen consumption rate plummits in the
presence of rotenone. These data suggests that NSPCs have the capacity to consume
oxygen via the electron transport chain.

Therefore, while NSPCs appear to have

functional electron transport it remains to be determined what role mitochondrial
respiration plays under sudden-onset hypoxia. Oxygen consumption and extracellular
acidification rates in postnatal NSPCs were not measured in this study, and it will be
important to expose them to a mitochondrial stress test in order to determine whether they
exhibit the same properties as embryonic NSPCs. It will also be important to take our
studies into an animal model to determine whether NSPCs exhibit similar properties in
vivo. For example, that NSPCs appear to utilize glycolysis in culture conditions should
be confirmed by studying NSPCs in the SVZ of adult mice. In addition, our nestinCreERT2/R26R-YFP/Hif1afl/fl triple transgenic mice could be used to determine whether
the endogenous NSPC response to stroke is neuroprotective, and if HIF-1 regulates the
neuroprotective effects of NSPCs in vivo.

5.7 Clinical Relevance and Conclusions
It has been well-realized that brain plasticity is critical in functional repair following
stroke, and that the cytogenic response to stroke aids in this repair process (Maysami et
al., 2008; Jin et al., 2010a). As reported in this dissertation, we found that the cytogenic
response may be important to rescue at risk tissue. We describe a role for HIF-1 in
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NSPC-mediated neuroprotection and the ability of NSPCs to survive severe hypoxia.
Understanding the NSPC response to hypoxia will be required if these mechanisms are to
be harnessed for therapeutic application.
The use of neural stem cells in therapy following stroke and other injuries is an attractive
avenue of basic and clinical research, given their regenerative capabilities and
differentiation potential. Even if cells that differentiate from neural stem cells do not
incorporate into the existing cicuitry, their ability to provide protection to existing cells
make them an intriguing candidate to assist in tissue repair.

The neuroprotective

properties of endogenous NSPCs may be important for limiting the expansion of the
lesion area following stroke. Our studies suggest that HIF-1-regulated VEGF may
underlie beneficial effects of exogenously transplanted cells. However, therapeutic use
of neural stem cells must proceed with caution. Their proliferative capacity makes them
susceptible to graft overgrowth and tumor formation (Seminatore et al., 2010). However,
given the limited treatment options for many diseases and injuries, understanding the
therapeutic use of neural stem cells have the potential to advance their use into the clinic.
The clinical relevance of our work may include the future use of small molecule
regulators of HIF-1 stability in the treatment of stroke. Inhibitors of prolyl hydroxlase
activity have been developed for promoting angiogenesis for treating ischemic lesions
(HIF-1 stabilizers) (Shen et al., 2009); various inhibitors of HIF-1, both at the protein
and mRNA levels, have been developed for treatment of cancers (Onnis et al., 2009). In
the case of stroke, one might envision acute administration of a drug that would enhance
HIF-1 stability in order to maximize the viability of the neural stem cell pool at early
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post-stroke periods. However, at later times it may be important to inhibit HIF-1
function if it is demonstrated that HIF-1 overexpression impairs neuronal differentiation
of NSPCs. Our transgenic mice will be very useful in delineating the role of HIF-1
during various phases of stroke injury.
Cytogenesis following stroke is a delayed response which results in long-term migration
of progenitor cells to the lesion but incorporation of few (approximately 0.2%) postmitotic neurons into the striatal circuitry (Arvidsson et al., 2002; Thored et al., 2006).
That the brain mounts a neurogenic response involving hundreds of thousands of SVZderived NSPCs following stroke (Arvidsson et al., 2002) may be a mechanism to rescue
surviving tissue rather than to regenerate it. Therapies using the endogenous NSPC
response to stroke will most-likely target long-term rehabilitation rather than acute
processes that result in immediate infarction. However, long-term rehabilitation may be
improved by enhancement of NSPC function to promote stem cell migration,
proliferative ability, or growth factor release.
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Appendix A: Supplemental Data Chapter 3

Figure A1: Dose-response curves of neurons and eNSPCs in the presence of
cellular respiration inhibitors. (A) cyanide (0.1-2 mM), (B) oligomycin (1-10 M),
(C) rotenone (0.1-100 M), and (D) 6-aminonicotinamide (6-AN; 1-1000 M).
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Figure A2: Visualization of mitochondria using (A) MitoTracker Red staining (60X
image) or (B) transmission electron microscopy. For immunocytochemistry in (A),
NSPCs were identified using an antibody against nestin (green). TEM scale bar = 250
nm.
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Appendix B: Supplemental Data Chapter 4

Figure B1: Dose-response to mitochondrial inhibitors.
(A-C) NestinT2
wt/wt
T2

CreER /R26R-YFP/Hif1a
and nestin-CreER /R26R-YFP/Hif1a cultures were
exposed to the following inhibitors for 24 h at normoxia: (A) cyanide (0.1-1 mM), (B)
oligomycin (0.1-10 M), and (C) rotenone (0.1-100 M). (D) Dose-response of wildtype and Hif1a embryonic NSPCs treated with Ad-CMV-Cre to cyanide (0.1-2 mM)
for 24 h at normoxia.
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C.1 Abstract
The purpose of this study was to ascertain the relative contribution of neural
stem/progenitor cells (NSPCs) of the subventricular zone (SVZ) to lineages that
repopulate the injured striatum following focal ischemia. We utilized a tamoxifeninducible Cre/loxP system under control of the nestin promoter, which provides
permanent YFP labeling of multipotent nestin+ SVZ-NSPCs prior to ischemic injury and
continued YFP expression in all subsequent progeny following stroke. YFP reporter
expression was induced in adult male nestin-CreERT2:R26R-YFP mice by tamoxifen
administration (180 mg kg-1, daily for 5 days). Fourteen days later, mice were subjected
to 60-min transient middle cerebral artery occlusion (MCAO) and sacrificed at 2 days, 2
weeks, or 6 weeks post-MCAO for phenotypic fate mapping of YFP+ cells using lineagespecific markers. Migration of YFP+ cells from SVZ into the injured striatal parenchyma
was apparent at 2 and 6 weeks, but not 2 days, post-MCAO. At 2 weeks post-MCAO, the
average percent distribution of YFP+ cells within the injured striatal parenchyma was as
follows: 10% Dcx+ neuroblasts, 15-20% oligodendrocyte progenitors, 59% GFAP+
astrocytes, and only rare NeuN+ postmitotic neurons. A similar phenotypic distribution
was observed at 6 weeks, except for an increased average percentage of YFP+ cells that
expressed Dcx+ (20%) or NeuN (5%). YFP+ cells did not express endothelial markers, but
displayed unique anatomical relationships with striatal vasculature. These results indicate
that nestin+ NSPCs within the SVZ mount a multilineage response to stroke that includes
a gliogenic component more predominant than previously appreciated.
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C.2

Introduction

A promising discovery in stroke research within the past decade is the SVZ response to
cerebral ischemia, which may contribute importantly to recovery and repair processes.
Focal cerebral ischemia stimulates a cytogenic response from SVZ of both adult rodent
(Arvidsson et al., 2002) and human brain (Jin et al., 2006; Macas et al., 2006; MartiFabregas et al., 2010).This response is characterized by proliferation of neural
stem/progenitor cells (NSPCs) within the SVZ and heterotypic migration of neuroblasts
from SVZ into the ischemic brain parenchyma. Although most ectopic neuroblasts
undergo cell death within the injured parenchyma, a small number survive and give rise
to postmitotic neurons that replace

0.2% of neurons that are lost to injury within the

peri-infarct region (Arvidsson et al., 2002; Thored et al., 2006). In addition to
neurogenesis, gliogenesis and angiogenesis contribute to brain repair following stroke,
but the relative contribution of the SVZ to new glial or endothelial cell phenotypes
following stroke has not been well characterized.
To ascertain the relative contribution of the SVZ-NSPCs to lineages that repopulate
striatum following focal cerebral ischemia, we utilized a tamoxifen-inducible Cre/loxP
system under control of the nestin promoter to genetically label a large cohort of nestin+
NSPCs within the SVZ prior to the onset of ischemic injury. Administration of tamoxifen
to nestin-CreERT2:R26R-YFP bitransgenic mice transiently activates Cre-mediated
recombination, resulting in permanent excision of a floxed transcriptional stop sequence
upstream of an YFP reporter gene sequence within nestin+ cells (Lagace et al., 2007).
This leads to permanent YFP reporter gene expression by NSPCs and all subsequent
progeny, thereby providing a genetic marker for tracking the migration of nestin
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derivatives and for phenotypic fate mapping. Here, we describe the use of nestinCreERT2:R26R-YFP mice to fate map both neuronal and nonneuronal SVZ derivatives
following focal cerebral ischemia induced by transient middle cerebral artery occlusion
(MCAO). Our results indicate that the cytogenic response of nestin+ NSPCs within the
SVZ is primarily gliogenic following stroke.
C.3 Materials and Methods
C.3.1 Mice
Animal experiments were approved by the University of New Mexico Animal Care and
Use Committee in accordance with the NIH Guide for the Care and Use of Laboratory
Animals. The generation and characterization of the nestin-CreERT2:R26R-YFP strain
used in this study were previously described (Lagace et al., 2007). All mice were housed
under a 12 h light: 12 h dark cycle with food and water available ad libitum.

C.3.2 Tamoxifen Administration
Male nestin-CreERT2:R26R-YFP mice (6- to 8-weeks old) were administered tamoxifen
dissolved in 10% EtOH/90% sunflower oil intraperitoneally (i.p) at the dose of 180 mg
kg-1 daily for 5 consecutive days. Control mice received vehicle injections. This dosing
regimen was previously demonstrated to provide maximal recombination with minimal
mortality (Lagace et al., 2007).

C.3.3 Middle Cerebral Artery Occlusion (MCAO)

133

Two weeks following the final injection of tamoxifen or vehicle, nestin-CreERT2:R26RYFP mice received 60-min transient MCAO or sham MCAO by intraluminal filament as
published previously (Kokovay et al., 2006).
C.3.4 Histology
Mice were overdosed with sodium pentobarbital (150 mg kg-1, i.p.; Fort Dodge Animal
Health, Fort Dodge, IA), and transcardially perfused with phosphate-buffered saline
(PBS) containing 0.1% procaine and 2 U mL-1 heparin, followed by 4%
paraformaldehyde (w/v) in 0.1 M PBS. The brains were postfixed overnight,
cryoprotected with 30% sucrose (w/v) in 0.1 M PBS for 48 h at 4°C and sectioned at 30
m thickness in the coronal plane using a freezing sliding knife mictrotome. Floating
sections were processed for immunofluorescence as previously published (Roitbak et al.,
2008) using the following primary antibodies: goat anti-doublecortin (Dcx; 1:200; Santa
Cruz Biotechnology, Santa Cruz, CA), mouse anti-glial fibrillary acidic protein (GFAP;
1:500, Sigma, St. Louis, MO), rabbit anti-GLUT-1 (1:200, Abcam, Cambridge, MA),
rabbit anti-NG2 (1:200; Millipore, Billerica, MA), rabbit anti-Olig2 (1:1,000; Millipore,
Billerica, MA), rabbit anti-laminin (1:500; Sigma, St. Louis, MO), chicken anti-GFP
(1:1,000; Invitrogen, Carlsbad, CA), rabbit anti-Iba-1 (1:500; Wako Chemicals USA,
Richmond, VA). Immunofluorescence was visualized using FITC-, CY3-, or Cy5conjugated secondary antibodies (1:250; Jackson ImmunoResearch Laboratories, West
Grove, PA). YFP immunofluorescence was visualized using biotinylated donkey
antichicken secondary antibody and Tyramide-Plus amplification (PerkinElmer Life
Sciences, Boston, MA) as previously described(Lagace et al., 2007). For Fluoro-Jade
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staining, histological sections were incubated with 0.05% potassium permanganate for 15
min, followed by 30 min in 0.001% Fluoro-Jade (Histo-Chem, Jefferson, AR).
Coexpression of YFP with lineage-specific markers was quantified by random sampling
of at least 100 YFP+ cells per mouse for each marker using a 40× oil objective on a Zeiss
LSM510 confocal microscope, coupled with rapid z-axis analysis at 1 m optical section
thickness. YFP+ cells were scored as positive or negative for coexpression of each
marker. Data are presented as the mean percentage of YFP+ cells coexpressing Dcx,
NeuN, NG2, Olig2, or GFAP ± SEM. Statistical analysis was performed using Students t
test, comparing data acquired from 2- vs. 6-week post-MCAO with P < 0.05 considered
significant.
C.4 Results
C.4.1 Stroke Induces Delayed Migration of YFP Reporter+ Cells from SVZ into Adjacent
Striatal Parenchyma
We utilized a previously published protocol for achieving maximum Cre-mediated
recombination in the nestin-CreERT2:R26R-YFP mice by administration of tamoxifen
(180 mg kg-1, i.p.) daily for five consecutive days (Lagace, 2007 #88). Two weeks were
allowed following the final injection for tamoxifen clearance, and the mice were then
subjected to 60 min transient MCAO (n = 12) or sham MCAO (n = 2). NestinCreERT2:R26R-YFP mice that received vehicle i.p. injections served as additional
controls (see below). Mice were sacrificed after 2 days (n = 4), 2 weeks (n = 4), or 6
weeks (n = 4) post-MCAO, and brain tissue was processed for histological evaluation of

135

stroke-induced neurodegeneration, distribution of YFP+ cells and phenotypic fate of
YFP+ cells using lineage-specific markers (see Fig. 1A for experimental design).
Neurodegeneration throughout the striatum was apparent as early as 2-days post-MCAO,
as evidenced by positive Fluoro-Jade staining throughout the striatum and parietal cortex
on the ischemic side (Fig. 1B), however, YFP+ cells remained localized to the SVZ and
were not observed within the adjacent striatal parenchyma at this early postinjury time
point (Fig. 1C). By 2-week post-MCAO, the density of YFP reporter+ cells was increased
throughout the SVZ and adjacent ischemic striatum, heavily populating the striatal
parenchyma on the ischemic side (Fig. 1D). A similar distribution and density of YFP+
cells within the injured striatum was apparent at 6 weeks (Supp. Info. Fig. 1A). YFP
reporter+ cells were not present within the contralateral striatum of tamoxifen-induced
nestin-CreERT2:R26R-YFP MCAO mice (Supp. Info. Fig. 1B), or within the ipsilateral
striatum of tamoxifen-induced mice that received sham MCAO surgery (Supp. Info. Fig.
1C).
C.4.2 YFP Reporter Fidelity is Maintained in Adult Nestin-CreERT2:R26R-YFP Mice
Following Stroke
Nestin-CreERT2:R26R-YFP mice that received vehicle i.p. injections were used to verify
the stringency of Cre-mediated recombination under conditions of cerebral ischemia. In
contrast to tamoxifen-treated mice, YFP+ cells were not observed within the SVZ or
within the injured striatal parenchyma of vehicle-injected nestin-CreERT2:R26R-YFP
mice as assessed at 2-weeks post-MCAO. However, Dcx+ migrating neuroblasts were
readily detected in vehicle-treated mice at this time point, confirming a normal
neurogenic response to stroke in this control group (Fig. 2A). Thus, Cre-mediated
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recombination does not occur in the absence of tamoxifen and does not occur
spontaneously in response to MCAO injury in vehicle-treated nestin-CreERT2:R26R-YFP
mice. In mice treated with tamoxifen 2 weeks prior to MCAO, YFP expression was also
not observed within reactive astrocytes that upregulate nestin following MCAO (Fig.
2B), indicating that the 14-day washout interval between tamoxifen administration and
MCAO was sufficient time to ensure that all recombination occurred prior to the onset of
ischemic injury. Taken together, these results verify the fidelity of the nestin-CreERT2
system under conditions of focal cerebral ischemia induced by transient 60-min MCAO.
C.4.3 Multilineage Analysis of YFP Reporter+ Cells
C.4.3.1 Neuronal lineage
To determine the relative proportion of YFP reporter+ cells within the ischemic striatum
that represent migratory neuroblasts and/or postmitotic neurons, histological sections
from tamoxifen-treated mice were assessed for co-labeling of YFP with Dcx or NeuN
immunofluorescence, respectively. Dcx+ neuroblasts were observed throughout the
ischemic striatum (Fig. 3A), but were not present within the contralateral striatum or
within the striatum of sham-operated controls (data not shown). Dcx+ cells comprised
10% ± 3% and 20% ± 1% of all YFP+ cells within the injured striatum at 2 and 6 weeks
post-MCAO, respectively (Fig. 3A-C). The majority of Dcx+ cells within the injured
straitum were negative for YFP reporter expression at both 2- and 6-weeks post-MCAO
(80% ± 3% and 67% ± 17%, respectively). YFP+ cells within the injured striatum that coexpressed the mature neuronal marker, NeuN, were only rarely observed at 2 weeks (<1
NeuN+/YFP+ colabeled cell per histological section, data not shown), but represented 5%
± 1% of all YFP+ cells by 6-weeks post-MCAO (Fig. 3D,E).
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C.4.3.2 Oligodendrocyte lineage
To determine the relative contribution of YFP+ cells to the oligodendrocyte lineage we
utilized NG2 proteoglycan and the transcription factor, Olig2, as markers of
oligodendrocyte progenitors (Fig. 4A,B). Triple labeling revealed that 15% ± 2% and
19% ± 4% of all YFP+ cells within injured striatum co-expressed both NG2 and Olig2
markers at 2 and 6 weeks post-MCAO, respectively (Fig. 4D). Only a small percentage of
YFP+ cells were Olig2+/NG2- (5% ± 2% and 5% ± 1% at 2 and 6 weeks, respectively).
YFP+ oligodendrocyte progenitors were abundant throughout the penumbral region that
spanned from lateral ventricle to infarct boundary, but were sparse within the SVZ in
both lesioned and unlesioned hemispheres (Fig. S2A, online). YFP+ oligodendrocyte
progenitors displayed a multiprocessed morphology and were negative for the microglial
marker, Iba1 (Fig. 4C). YFP+ cells immunofluorescent for the mature oligodendrocyte
markers, CC1 or RIP, were not observed at 2- or 6-weeks post-MCAO, although YFP+
cells with morphology reminiscent of mature oligodendrocytes were observed within the
corpus callosum (Supp. Info. Fig. 2B).
C.4.3.3 Astrocyte lineage
YFP reporter+ cells that co-expressed the astrocytic marker, GFAP, were abundant within
the penumbral regions between lateral ventricle and ischemic core; 58% ± 4% and 45% ±
7% of all YFP+ cells were co-labeled with GFAP at 2 and 6 weeks, respectively (see Fig.
5). GFAP+/YFP+ co-labeled cells displayed diverse morphologies ranging from
multipolar highly branched hypertrophied astrocytes (Fig. 5A) to radial glia-like
morphologies characterized by long slender sparsely branched processes (Fig. 5B).
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C.4.3.4 YFP+ Cells Display Unique Anatomical Relationships with Striatal Vasculature
Previous studies have demonstrated that exposure of isolated neural stem cells to
endothelial cells in co-culture can induce neural stem cell expression of endothelial
lineage markers(Roitbak et al., 2008). Since stroke-induced neurogenesis is thought to
occur within an angiogenic niche, we assessed vascular phenotype in YFP+ cells in the
MCAO paradigm using laminin and the high affinity Glut-1 glucose transporter.
Although we did not observe YFP+ cells that adopted an endothelial cell fate, co-labeling
with endothelial markers revealed a striking relationship of YFP+ cells with
microvasculature, both within the SVZ and within the ischemic striatum. As shown in
Fig. 6, YFP reporter+ cells within the SVZ were found to extend long radial processes
from the SVZ into the surrounding brain parenchyma to terminate an endfoot-like
terminal on capillaries (Fig. 6B). These cells likely represent B1 type astrocytic stem
cells(Doetsch, 2003a). These cells were observed within the base of the SVZ at the level
of medial septum, near the nucleus accumbens on both injured and uninjured
hemispheres, and extended processes up to 180

m in length to terminate on blood

vessels. Most SVZ-derived YFP reporter+ cells that had migrated into ischemic striatum
were found in close physical contact with vasculature, with soma either directly
juxtaposed to blood vessels or contacting blood vessels via endfoot-like processes (Fig.
6C,D). In some cases, YFP+ cells were closely associated with fine endothelial
extensions that connected adjacent capillaries reminiscent of angiogenic microvasculature
(Fig. 6D).
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C.5 Discussion
In the present study, we utilized tamoxifen inducible nestin-CreERT2:R26R-YFP mice to
label a large cohort of NSPCs within the adult subventricular zone prior to injury and
followed migration and lineage fate of the NSPCs out to 6-weeks post-MCAO. This
genetic fate-mapping approach permits long-term evaluation of a large cohort of SVZ
NSPCs using an irreversible YFP reporter system, thereby enabling a comprehensive
examination of lineage fate following stroke.
We found that Dcx+ neuroblasts accounted for up to 20% of all YFP+ cells within the
ischemic striatal parenchyma by 6-weeks post-MCAO. In mouse, transgenic ablation of
Dcx-expressing cells worsens stroke outcome (Jin et al., 2010a) indicating that these cells
may be an important therapeutic target. Although NeuN+/YFP+ co-labeled cells were only
sparsely represented at 2 weeks, their numbers increased to 5% of all YFP+ cells by 6weeks post-MCAO. Since

80% of migrating neuroblasts were YFP- in our study, it is

likely that up to 20% of all neuroblasts survive to become NeuN+ postmitotic neurons by
6-weeks post-MCAO, which is consistent with previous estimates (Arvidsson et al.,
2002). The presence of Dcx+/YFP- cells may reflect suboptimal labeling efficiency within
SVZ, since previous studies have demonstrated that Dcx+ neuroblasts within ischemic
striatum arise primarily from SVZ astrocytic stem cells of the nestin lineage (Yamashita
et al., 2006). A previous study by Burns et al. (Burns et al., 2007)using a different strain
of tamoxifen-inducible nestin-CreER:GFP bitransgenic mice reported only very few
GFP-positive cells outside the SVZ following MCAO. Ectopic migration of Dcx+
neuroblasts into the ipsilateral striatum was negligible in that study, possibly due to the
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early time point of analysis at 1-week post-MCAO or due to less effective MCAOinduced injury.
We found that 18-21% of all YFP reporter+ cells within the injured striatal parenchyma at
6-weeks post-MCAO represent NG2+/Olig2+ oligodendrocyte progenitor cells. NG2 is a
chondroitin sulfate proteoglycan expressed on the surface of oligodendrocyte progenitors
(Nishiyama et al., 2009), and Olig2 is a transcription factor necessary for the
development of the oligodendrocyte lineage (Takebayashi et al., 2002). In adult brain,
the majority of Olig2+ progenitor cells within the white matter transiently co-express
NG2 and eventually give rise to NG2- oligodendrocytes, whereas in grey matter most
Olig2+ cells remain as nonproliferating Olig2+/NG2+ progenitors (Dimou et al., 2008).
Our study suggests that the latter population of oligodendrocyte progenitors is partially
replaced by SVZ-NSPCs following stroke, since we did not observe co-labeling for
mature oligodendrocyte markers within the ischemic parenchyma, even by 6 weeks.
GFAP+ astrocytes comprise the largest fraction of all YFP reporter+ cells within the
ischemic striatum at both 2 weeks (59%) and 6 weeks (45%) post-MCAO. Astrocytes are
a heterogeneous population of cells within the CNS that play both beneficial and
detrimental roles following injury (Sofroniew, 2009). Glial scarring within the CNS is
recognized as a major impediment to neurite outgrowth and regeneration(Silver and
Miller, 2004). In contrast, ablation of reactive astrocytes in adult mice (Bush et al., 1999)
or disruption of cytokine signaling in reactive astrocytes (Okada et al., 2006; Herrmann et
al., 2008) leads to spread of inflammation and increased injury responses. Furthermore,
GFAP-null mice demonstrate increased kainate excitoxicity (Otani et al., 2006).
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Pharmacological inhibition of reactive astrocytes with fluorocitrate retards neurovascular
remodeling and recovery after focal cerebral ischemia (Hayakawa et al., 2010). Recent
studies have shown that neural stem cells within the spinal cord give rise to a functionally
distinct subset of astrocytes following injury, which do not produce axonal growth
inhibitory chondroitin sulfate proteoglycans (CSPGs) and appear to promote axonal
sprouting (Meletis et al., 2008). Buffo et al. recently reported that mature astrocytes have
the capacity to re-enter the cell cycle, dedifferentiate and resume multipotency in
response to brain injury (Buffo et al., 2008). Future studies will be required to determine
the extent to which SVZ-derived astrocytes within the ischemic parenchyma promote
regenerative processes vs. contribute to glial scarring and inhibition of neurite outgrowth
following focal ischemia.
YFP reporter+ cells displayed unique anatomical association with microvasculature
within the SVZ and ischemic striatal parenchyma. Many YFP+ cells within the SVZ were
found to extend a long basal process from the SVZ into the brain parenchyma to make
contact with blood vessels through an endfoot-like structure. Mirzadeh et al. recently
demonstrated that >95% of type B1 astrocytes within the SVZ have an apical ciliated
process that is in contact with the ventricle, and a long basal process that extends several
hundred microns into the brain parenchyma to contact a blood vessel via an endfoot
(Mirzadeh et al., 2008). The functional significance of vascular contact of neural stem
cells may reflect the need for vascular-derived factors important in maintaining the stemcell phenotype (Shen et al., 2004), or allow signals from CSF and bloodstream to be
integrated (Tavazoie et al., 2008). Neural stem cells within the SVZ are also associated
with extravascular basal lamina unique to the subependymal layer, termed fractones,
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purported to provide a specialized extracellular matrix within the neural stem cell niche
(Mercier et al., 2002).
YFP+ cells were also found in close association with the microvasculature throughout the
injured striatum. This anatomical relationship likely reflects the use of vascular basal
lamina as a migratory substrate (Ohab et al., 2006), and/or the importance of reciprocal
signaling between SVZ derivatives and nascent vasculature during the repair process
(Louissaint et al., 2002; Roitbak et al., 2008). The migration of neuroblasts along
nonstereotypical routes toward the injured area occurs in response to chemotactic growth
factors and chemokines that also signal angiogenesis, including stromal cell-derived
growth factor (SDF-1) (Imitola et al., 2004), vascular endothelial growth factor (VEGF)
(Zhang et al., 2003a) and angiopoietin 2 (Liu et al., 2009). SDF-1- and VEGF-induced
migration of adult NSPCs in culture is mediated by matrix metalloproteinase (MMP)-3
and MMP-9 expression and activation in NSPCs (Barkho et al., 2008). Pharmacological
inhibition of MMP activity also impairs stroke-induced neurogenesis in vivo (Lee et al.,
2006). Thus, the angiogenic and neurogenic responses to stroke are tightly linked.
In conclusion, our genetic-lineage tracing study shows that stroke induces a multilineage
cytogenic response in which nestin+ neural stem cells of the SVZ produce neuroblasts,
postmitotic neurons, oligodendrocyte progenitor cells, and astrocytic cells that repopulate
the striatal parenchyma out to at least 6 weeks following the ischemic event. These
studies are important in light of recent evidence for increased proliferation of GFAP+
cells within the ribbon layer of human ipsilateral SVZ at early times following stroke
(Marti-Fabregas et al., 2010) and subsequent appearance of cells expressing markers of
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newborn neurons (PSA-NCAM and Dcx) within the infarct penumbra of human brain
weeks following the onset of stroke symptoms (Jin et al., 2006; Macas et al., 2006). A
recent study by (Ohira et al., 2010), provides evidence for cortical neurogenesis from
nonnestin derivatives within subpial regions of the neocortex in response to global
forebrain ischemia in mice (Ohira et al., 2010). In addition, induced repetitive cortical
spreading depression, an epiphenomenon of stroke injury in humans and rodents, has
recently been reported to stimulate hippocampal neurogenesis and subpial cortical
neurogenesis (Yanamoto et al., 2005; Urbach et al., 2008). However, we did not observe
contribution of YFP+ cells to superficial gliosis or evidence for cellular migration from
subpial regions of cortex following MCAO.
An important finding of the current study is the percent distribution of YFP+ SVZ
derivatives; in which glia represent

67-78% of all YFP reporter+ cells, indicating a

significant gliogenic component. It is currently unclear whether YFP+ SVZ cells adopt a
glial fate prior to migration or after they arrive within the striatal parenchyma. Previous
studies have shown that transplantation of multipotent SVZ cells directly into
nonneurogenic brain regions limits neurogenic potential and promotes astrocyte
differentiation (Alvarez-Buylla and Lim, 2004; Zheng et al., 2006), underscoring the
importance of microenvironment in determining NSPC lineage fate. The current studies
provide a baseline for the use of nestin-CreERT2 transgenic mice to study the molecular
regulation of migration and differentiation of NSPCs following ischemic injury through
selective knockout or overexpression of genes within nestin+ NSPCs and their progeny.
Understanding the molecular regulation of lineage fate of NSPCs following injury should
lead to improved strategies for facilitating structural and functional recovery.

144

C.6 Figure Legends
Figure C.1. (A) Experimental design. (B) Fluoro-Jade at Day 2 post-MCAO. (C) YFP
immunofluorescence 2-days post-MCAO. (D) YFP immunofluorescence at 2-weeks postMCAO. LV (lateral ventricle), ST (Striatum). Scale Bars = 100 m.
Figure C.2. (A) Dcx (red) and YFP (green) immunofluorescence in vehicle-injected
control Nestin-CreERT2:R26R-YFP mice. (B) Nestin (red), GFAP (blue), and YFP
(green) immunofluorescence in tamoxifen-treated Nestin-CreERT2:R26R-YFP mice at
Day-14 post-MCAO. LV (lateral ventricle). Scale bar = 100 m.
Figure C.3. (A) Doublecortin (red) and YFP (green) immunofluorescence at 2-weeks
post-MCAO. (B) Higher power images with orthogonal view of confocal z-stack.
DCX+/YFP+ cells (arrows) and DCX-/YFP+ cells (arrowheads). (C,E) Percentage of YFP
reporter+ cells that co-express Dcx (C) or NeuN (E). (D) NeuN+ (red) and YFP (green)
immunofluorescence at 6-weeks post-MCAO. ND = <1 cell per section. *P < 0.05. Scale
bars = 100 m (A), 10 m (B), or 20 m (D).
Figure C.4. Dual immunofluorescence for YFP (green) with (A) NG2 (red) (B) Olig2
(red) and (C) Iba-1 (red) at 2-weeks post-MCAO. (D) Percentage of YFP+ cells that
express Olig2 and NG2 at 2- and 6-weeks post-MCAO. Scale bars = 20 m (A,C) or 10
m (B).
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Figure C.5. Dual immunofluorescence for YFP (green) with GFAP (red or blue) at 2weeks post-MCAO. Graph depicts the percentage of YFP+ cells that express GFAP at 2and 6-weeks post-MCAO. Scale bars = 20 m.
Figure C.6. (A) Boxed images on histological section are shown in higher power in B-D.
Solid area represents region of ischemic damage. (B) Dual immunofluorescence for YFP
(green) and GLUT-1 (red) demonstrating YFP+ processes from radial glial-like cells in
the SVZ with endothelial end-feet. (C) YFP reporter+ cells (green) that have migrated
into the ischemic border zone and are associated with laminin+ (red) cerebral blood
vessels. (D) YFP reporter+ cells (green) within the ischemic striatum associated with
processes of laminin+ (red) angiogenic blood vessels. Scale bars = 10 m (B-D).
Supporting Information Figure 1. A) YFP+ cells within the ischemic striatum at 6
weeks post-MCAO. B) YFP immunofluorescence on the non-ischemic hemisphere of a
tamoxifen-injected mouse at 2 weeks post-MCAO. C) YFP (green) and NeuN (red)
immunofluorescence of ipsilateral hemisphere 2 weeks after sham MCAO surgery. CTX
(cortex), STM (striatum). Scale bars = 100 m (A) or 20 m (B,C).
Supporting Information Figure 2. A) YFP and Olig2 (left) or NG2 (right)
immunofluorescence within the subventricular zone. B) YFP+ cells within the corpus
callosum (CC); higher power shown on right panel. LV (lateral ventricle). Scale bars = 10
m.
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Figure C.1 Experimental design.
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Figure C.2 Dcx and YFP immunofluorescence following MCAO
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Figure C.3 Dcx and NeuN immunofluorescence 2 weeks post-MCAO
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Figure C.4 NG2, Olig2, and Iba-1 immunofluorescence 2 weeks post-MCAO
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Figure C.5 GFAP immunofluorescence 2 and 6 weeks post-MCAO
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Figure C.6 Glut-1 and laminin immunofluorescence
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Supporting Information Figure C.1
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Supporting Information Figure C.2
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D.1 NSPC-HIF-1 gene deletion results in cell autonomous NSPC depletion in SVZ
and SGZ under non-pathological conditions
To determine the effect of NSPC-HIF-1 gene deletion in vivo, tamoxifen was
administered to triple transgenic mice (nestin-CreERT2/R26R-YFP/Hif1afl/fl) and the mice
were sacrificed 2 weeks later.

In the triple transgenic mice, tamoxifen induces

simultaneous and irreversible Cre-mediated recombination at the R26R-YFP and Hif1afl/fl
loci yielding nestin-CreERT2/R26R-YFP/Hif1a NSPCs in which YFP reporter
expression is activated and HIF-1 exon 2 is deleted from genomic DNA in the same
cells. Nestin-CreERT2/R26R-YFP double transgenics that do not harbor floxed Hif1a
exon 2 received the same tamoxifen dosing regimen and served as controls (nestinCreERT2/R26R-YFP/Hif1awt/wt). As shown in Figure D1, Hif1a gene deletion resulted in
depletion of YFP+ cells throughout the SVZ (compare A vs. B). YFP+ NSPC depletion
was even more pronounced within the SGZ, where only sparse YFP+ cells were observed
two weeks following in vivo recombination (compare C vs. D). Noticeably, the negative
impact of Hif1a gene deletion on the NSPC pool appears to be a cell-autonomous effect,
since Dcx+ neuroblasts were observed throughout the SGZ in the nestin-CreERT2/R26RYFP/Hif1a mice, indicating that Hif1a gene deletion did not impair neurogenesis in
non-recombined cells.

These results also suggest the possibility of suboptimal

recombination efficiency, or that Dcx+ neuroblasts observed in D represent those existing
prior to TM induction.

Future dosing regimens will be tested for optimized

recombination efficiency, by increasing the number of dosing cycles or by providing
tamoxifen orally through drinking water or gavage. In the interim, we propose a focuses
series of experiments to elucidate the in vivo mechanisms that underlie HIF-1 regulation
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of stem cell pool and subsequent phenotypic fate by restricting analysis to YFP reporter
cells.
D.2 NSPC-Hif1a gene deletion impairs the cytogenic response to stroke
To determine the effects of NSPC-Hif1a gene deletion on the SVZ cytogenic response to
stroke, triple or double transgenic mice received tamoxifen injections as described above
and were subjected to 60 minute transient MCAO 14 days following the final injection.
The mice were sacrificed at 2 weeks post-MCAO. As anticipated, fewer YFP+ cells were
observed within the injured striatum of nestin-CreERT2/R26R-YFP/Hif1a mice
compared to tamoxifen treated control mice (Fig. D2). This is likely due to decreased
numbers of YFP+ cells in the stem cell pool prior to injury as described above, coupled
with reduced survival and/or proliferation of Hif1a NSPCs following stroke.
Nevertheless, some YFP+ Hif1a NSPCs survived the injury and migrated into the
ischemic striatum. Preliminary phenotypic analysis suggests that Hif1a gene deletion,
while decreasing the total number of YFP+ cells within the ischemic striatum, increases
the percentage of YFP+ cells that express the neuroblasts marker Dcx at 2 weeks postMCAO (Fig. D3).
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Figure D1. YFP+ reporter expression in SVZ (left) and SGZ (above) 2 weeks following
TM injections to nestin-CreERT2/R26R-YFP/Hif1awt/wt (A,C) or nestin-CreERT2/R26RYFP/Hif1afl/fl mice (B,D). Note that Hif1a gene deletion resulted in depletion of YFP+
cells throughout the SVZ and SGZ. Dual labeling for YFP and DCX in D revealed many
non-YFP+ neuroblasts indicating that Hif1a gene deletion resulted in NSC autonomous
depletion and did impair neurogenesis in non-recombined cells.
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Figure D2. YFP reporter expression within the ischemic striatum in nestinCreERT2/R26R-YFP/Hif1a+/+ (left) and nestin-CreERT2/R26R-YFP/Hif1a (right)
mice at 2 weeks post-MCAO.

Figure D3. Percentage of YFP+ cells that co-express DCX within ischemic striatum at
2 weeks following MCAO.
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Abbreviations Used
2-DG

2-deoxy-D-glucose

4-OH-TM

4-hydroxy-tamoxifen

6-AN

6-aminonicotinamide

ADP

Adenosine diphosphate

ANOVA

Analysis of variance

ARNT

Aryl hydrocarbon receptor nuclear translocator

ATP

Adenosine triphosphate

BDNF

Brain derived neurotrophic factor

bFGF

Basic fibroblast growth factor

BrdU

Bromodeoxyuridine

CCA

Common carotid artery

CMV

Cytomegalovirus

CN

Cyanide

Cy

Cyanine

DAPI

4',6-diamidino-2-phenylindole

DCA

Dichloroacetate

Dcx

Doublecortin

DIV

Days in vitro

DNA

Deoxyribonucleic acid

EGF

Epidermal growth factor

EPO

Erythropoietin

GFAP

Glial fibrillary acidic protein

GFP

Green fluorescent protein

EBSS

Earle’s balanced salt solution
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ECAR

Extracellular acidification rate

EGFP

Enhanced green fluorescent protein

FITC

Fluorescein isothiocyanate

FCCP

Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone

HIF

Hypoxia-inducible factor

HRE

Hypoxia response element

HSP

Heat shock protein

ICD

Intracellular domain

LDH

Lactate dehydrogenase

MCAO

Middle cerebral artery occlusion

MCT

Monocarboxylate transporter

MOI

Multiplicities of infection

MPO

Myeloperoxidase

NAD(P)H

Nicotinamide adenine dinucleotide (phosphate)

NIH

National Institutes of Health

NSPC

Neural stem/progenitor cell

OCR

Oxygen consumption rate

OGD

Oxygen-glucose deprivation

PBS

Phosphate buffered saline

PCR

Polymerase chain reaction

PDH

Pyruvate dehydrogenase

PDK

Pyruvate dehydrogenase kinase

PSA-NCAM

Polysialylated neural cell adhesion molecule

ROS

Reactive oxygen species

SDF

Stromal derived factor
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SGZ

Subgranular zone

SVZ

Subventricular zone

TCA

Tricarboxylic acid cycle

TEM

Transmission electron microscopy

TM

Tamoxifen

tPA

Tissue plasminogen activator

Tuj1

Neuron-specific class III beta-tubulin

TUNEL

Terminal deoxynucleotidyl transferase dUTP nick end labeling

VEGF

Vascular Endothelial Growth Factor

VHL

von Hippel-Lindau

YFP

Yellow fluorescent protein
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